A list of FDA-approved influenza vaccines in US market as of March 2016.
\r\n\t
",isbn:null,printIsbn:"979-953-307-X-X",pdfIsbn:null,doi:null,price:0,priceEur:0,priceUsd:0,slug:null,numberOfPages:0,isOpenForSubmission:!1,isSalesforceBook:!1,isNomenclature:!1,hash:"fb62b55d29b360cbfd0efa1fcf5a2546",bookSignature:"Dr. Taro Kakinuma",publishedDate:null,coverURL:"https://cdn.intechopen.com/books/images_new/7316.jpg",keywords:"Groundwater, Well, Slope Stability, Soil Structure, Saltwater Intrusion, Salt-Water Wedge, Metal Corrosion, Ion Concentration, Tide, Water Waves, Viscosity, Molten Rock",numberOfDownloads:null,numberOfWosCitations:0,numberOfCrossrefCitations:0,numberOfDimensionsCitations:0,numberOfTotalCitations:0,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"June 23rd 2020",dateEndSecondStepPublish:"July 14th 2020",dateEndThirdStepPublish:"September 12th 2020",dateEndFourthStepPublish:"December 1st 2020",dateEndFifthStepPublish:"January 30th 2021",dateConfirmationOfParticipation:null,remainingDaysToSecondStep:"2 years",secondStepPassed:!0,areRegistrationsClosed:!0,currentStepOfPublishingProcess:5,editedByType:null,kuFlag:!1,biosketch:"Worked as a Researcher at the Earthquake Research Institute, The University of Tokyo, and as a Researcher at the Port and Airport Research Institute, currently, he is affiliated with Kagoshima University.",coeditorOneBiosketch:null,coeditorTwoBiosketch:null,coeditorThreeBiosketch:null,coeditorFourBiosketch:null,coeditorFiveBiosketch:null,editors:[{id:"183830",title:"Dr.",name:"Taro",middleName:null,surname:"Kakinuma",slug:"taro-kakinuma",fullName:"Taro Kakinuma",profilePictureURL:"https://mts.intechopen.com/storage/users/183830/images/system/183830.png",biography:"Dr. Taro Kakinuma is affiliated with Kagoshima University since 2007 as an associate professor. He was a Center of Excellence Researcher at the Earthquake Research Institute, The University of Tokyo, and a Researcher at the Port and Airport Research Institute, Independent administrative Institution. Dr. Kakinuma obtained his Ph.D. in Civil Engineering at The University of Tokyo in 1997.",institutionString:"Kagoshima University",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"2",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"Kagoshima University",institutionURL:null,country:{name:"Japan"}}}],coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"10",title:"Earth and Planetary Sciences",slug:"earth-and-planetary-sciences"}],chapters:null,productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},personalPublishingAssistant:{id:"297737",firstName:"Mateo",lastName:"Pulko",middleName:null,title:"Mr.",imageUrl:"https://mts.intechopen.com/storage/users/297737/images/8492_n.png",email:"mateo.p@intechopen.com",biography:"As an Author Service Manager my responsibilities include monitoring and facilitating all publishing activities for authors and editors. From chapter submission and review, to approval and revision, copyediting and design, until final publication, I work closely with authors and editors to ensure a simple and easy publishing process. I maintain constant and effective communication with authors, editors and reviewers, which allows for a level of personal support that enables contributors to fully commit and concentrate on the chapters they are writing, editing, or reviewing. I assist authors in the preparation of their full chapter submissions and track important deadlines and ensure they are met. I help to coordinate internal processes such as linguistic review, and monitor the technical aspects of the process. As an ASM I am also involved in the acquisition of editors. Whether that be identifying an exceptional author and proposing an editorship collaboration, or contacting researchers who would like the opportunity to work with IntechOpen, I establish and help manage author and editor acquisition and contact."}},relatedBooks:[{type:"book",id:"5962",title:"Estuary",subtitle:null,isOpenForSubmission:!1,hash:"43058846a64b270e9167d478e966161a",slug:"estuary",bookSignature:"William Froneman",coverURL:"https://cdn.intechopen.com/books/images_new/5962.jpg",editedByType:"Edited by",editors:[{id:"109336",title:"Prof.",name:"William",surname:"Froneman",slug:"william-froneman",fullName:"William Froneman"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1591",title:"Infrared Spectroscopy",subtitle:"Materials Science, Engineering and Technology",isOpenForSubmission:!1,hash:"99b4b7b71a8caeb693ed762b40b017f4",slug:"infrared-spectroscopy-materials-science-engineering-and-technology",bookSignature:"Theophile Theophanides",coverURL:"https://cdn.intechopen.com/books/images_new/1591.jpg",editedByType:"Edited by",editors:[{id:"37194",title:"Dr.",name:"Theophile",surname:"Theophanides",slug:"theophile-theophanides",fullName:"Theophile Theophanides"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3161",title:"Frontiers in Guided Wave Optics and Optoelectronics",subtitle:null,isOpenForSubmission:!1,hash:"deb44e9c99f82bbce1083abea743146c",slug:"frontiers-in-guided-wave-optics-and-optoelectronics",bookSignature:"Bishnu Pal",coverURL:"https://cdn.intechopen.com/books/images_new/3161.jpg",editedByType:"Edited by",editors:[{id:"4782",title:"Prof.",name:"Bishnu",surname:"Pal",slug:"bishnu-pal",fullName:"Bishnu Pal"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3092",title:"Anopheles mosquitoes",subtitle:"New insights into malaria vectors",isOpenForSubmission:!1,hash:"c9e622485316d5e296288bf24d2b0d64",slug:"anopheles-mosquitoes-new-insights-into-malaria-vectors",bookSignature:"Sylvie Manguin",coverURL:"https://cdn.intechopen.com/books/images_new/3092.jpg",editedByType:"Edited by",editors:[{id:"50017",title:"Prof.",name:"Sylvie",surname:"Manguin",slug:"sylvie-manguin",fullName:"Sylvie Manguin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"371",title:"Abiotic Stress in Plants",subtitle:"Mechanisms and Adaptations",isOpenForSubmission:!1,hash:"588466f487e307619849d72389178a74",slug:"abiotic-stress-in-plants-mechanisms-and-adaptations",bookSignature:"Arun Shanker and B. Venkateswarlu",coverURL:"https://cdn.intechopen.com/books/images_new/371.jpg",editedByType:"Edited by",editors:[{id:"58592",title:"Dr.",name:"Arun",surname:"Shanker",slug:"arun-shanker",fullName:"Arun Shanker"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"72",title:"Ionic Liquids",subtitle:"Theory, Properties, New Approaches",isOpenForSubmission:!1,hash:"d94ffa3cfa10505e3b1d676d46fcd3f5",slug:"ionic-liquids-theory-properties-new-approaches",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/72.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"314",title:"Regenerative Medicine and Tissue Engineering",subtitle:"Cells and Biomaterials",isOpenForSubmission:!1,hash:"bb67e80e480c86bb8315458012d65686",slug:"regenerative-medicine-and-tissue-engineering-cells-and-biomaterials",bookSignature:"Daniel Eberli",coverURL:"https://cdn.intechopen.com/books/images_new/314.jpg",editedByType:"Edited by",editors:[{id:"6495",title:"Dr.",name:"Daniel",surname:"Eberli",slug:"daniel-eberli",fullName:"Daniel Eberli"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"57",title:"Physics and Applications of Graphene",subtitle:"Experiments",isOpenForSubmission:!1,hash:"0e6622a71cf4f02f45bfdd5691e1189a",slug:"physics-and-applications-of-graphene-experiments",bookSignature:"Sergey Mikhailov",coverURL:"https://cdn.intechopen.com/books/images_new/57.jpg",editedByType:"Edited by",editors:[{id:"16042",title:"Dr.",name:"Sergey",surname:"Mikhailov",slug:"sergey-mikhailov",fullName:"Sergey Mikhailov"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1373",title:"Ionic Liquids",subtitle:"Applications and Perspectives",isOpenForSubmission:!1,hash:"5e9ae5ae9167cde4b344e499a792c41c",slug:"ionic-liquids-applications-and-perspectives",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/1373.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"2270",title:"Fourier Transform",subtitle:"Materials Analysis",isOpenForSubmission:!1,hash:"5e094b066da527193e878e160b4772af",slug:"fourier-transform-materials-analysis",bookSignature:"Salih Mohammed Salih",coverURL:"https://cdn.intechopen.com/books/images_new/2270.jpg",editedByType:"Edited by",editors:[{id:"111691",title:"Dr.Ing.",name:"Salih",surname:"Salih",slug:"salih-salih",fullName:"Salih Salih"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},chapter:{item:{type:"chapter",id:"52621",title:"Steps toward a Universal Influenza Vaccine: Research Models and Comparison of Current Approaches",doi:"10.5772/64369",slug:"steps-toward-a-universal-influenza-vaccine-research-models-and-comparison-of-current-approaches",body:'\nThe World Health Organization (WHO) estimates 3–5 million cases of severe influenza worldwide will result between 250,000 and 500,000 deaths annually [1]. Within the United States, 24.7 million cases of seasonal influenza of various severities are predicted and an estimated 3,300–49,000 deaths occurred per year between 1979 and 2001 [2]. From 2013 to 2014, the hospitalization rate in the United States was 24.6 per 100,000 persons [3], although rates as high as 309 per 100,000 have been reported from 1993 to 2008, among elderly >65 years of age [4]. Including direct medical costs and loss of productivity and earnings associated with work absentness, seasonal influenza contributes an $87 billion burden on the US economy [5]. Furthermore, the spread of pandemic swine influenza virus from 2009 to 2010 attributed to 42–89 million cases of pandemic H1N1 (pdm H1N1) and an estimated 8870–18,300 deaths. Consequently, there is still a need to enhance our understanding of influenza virus evolution and manage the spread of pandemic influenza viruses.
\nGlobal influenza virus monitoring and surveillance systems track significant trends or real-time changes to influenza epidemiology and identify predominant viral subtypes during a particular season. Clinical symptoms include acute onset of cough, fever, and myalgia [6–9], and viral presence is confirmed by WHO-mandated laboratory standard operating procedures, such as immunostaining, cell culture growth, real-time polymerase chain reaction (RT-PCR), and detection of hemagglutination-inhibiting or viral neutralizing antibodies [10]. While viral culture in mammalian cells remains vital for characterization, RT-PCR remains the most rapid and sensitive diagnostic test available, with detection rates enhanced twofold over cell culture [8, 11, 12]. Alternatively, increases in hemagglutination-inhibiting antibody titers more than fourfold are counted as positive seroconversion and following viral infection or vaccination, which assists with monitoring immunogenicity. Collectively, data are shared through the WHO’s Global Influenza Surveillance and Response System (GISRS), which includes 143 institutions in 113 WHO Member States [13], to help alert the emergence of antigenic variants or the beginning of a pandemic.
\nIn April 2009, the Centers of Disease Control and Prevention (CDC) cited the first incidence of human-to-human transmission of pdmH1N1, also referred to as swine influenza A, which was antigenically distinct from other circulating human H1N1 [14]. As the first influenza pandemic of the twenty-first century, pandemic (pdm) H1N1 was not included in the annual trivalent vaccine regimen, leaving a large majority of the population unprotected from the newly emerging pathogen. In response to the increasing number of illnesses associated with pdm H1N1, satellite surveillance sites throughout the world rapidly collected clinical samples, surveyed seroconversion rates, and monitored the spread of the pandemic. Under the recommendation of WHO and CDC, the standard trivalent vaccine regimen of 2009–2010 [15] was reformulated to accommodate for the pdm H1N1 influenza strain (A/California/07/2009-like) [16, 17], and a median seroconversion rate of 59% was observed among healthy individuals ranging from 18 to 65 years of age [18]. During the 2010–2011 season, predicted efficacy in Sweden among individuals between 6 months and 64 years was between 63% and 80%, when 60% of the Swedish population received a monovalent AS03-adjuvanted vaccine against pdm H1N1 [19]; importantly, laboratory diagnosis of pdm09 H1N1 was utilized in this study. As of 2016, A/California/07/2009-like pdm H1N1 remains the predominant H1N1 strain circulating in the human population and remains a component in the annual trivalent or quadrivalent vaccine schedule. The remaining components of the annual vaccine, including prototype strains of Group B influenza strains and subtype H3N2, are frequently updated due to frequent antigenic changes to the hemagglutinins (HA). Ultimately, the WHO and CDC provide recommendations for vaccine formulation and identify what particular health concerns need to be address by the public, healthcare workers, and pharmaceutical/biomedical research industry.
\nCurrently, there are three types of influenza (A, B, and C), however, only types A and B infect humans. Influenza belongs to the family of Orthomyxoviridae and contains a negative sense, single segmented RNA genome. The influenza virion is pleomorphic or filamentous in shape, budding to approximately 80–120 nm in diameter, and attaches to sialic acid receptors found on numerous tissues in a diverse variety of hosts, including birds and mammals, such as swine, equine, canine, ferrets, and primates [20–23]. Upon budding from host cells, a lipid bilayer envelopes the viral ribonucleoprotein complex and presents surface viral glycoproteins, which are various combinations of hemagglutinins (HA, H1-H18) and neuraminidases (NA, N1-N11); the arrangement of HA and NA help distinguish the large diversity of influenza subtypes [24].
\nAvian influenza strains are ubiquitous in the wild; circulating in predominantly the wild ducks Anatidae bird populations [25–27] through an indirect fecal-oral transmission route and often results in little to no pathology [25, 28]. Replication of avian influenza virus (AIV) occurs in the intestinal tract of waterfowl and is shed in feces, such that contaminated waters infect other hosts; certain strains of AIV can persist in aquatic environments for 9 to 200 days, depending on salinity, pH, and temperature [29–31]. Consequently, poor water quality control and cohabitation of wild species increase the likelihood of AIV transmission into domestic birds markets [27, 32, 33] and livestock. Surveillance of live poultry markets in Asia indicate high prevalence of low pathogenic avian influenza strains, such as H3N2, H5N2, and H9N2 [32, 34–37]; isolates collected from poultry populations in Korea were used to experimentally infect mice and demonstrate zoonotic adaptation for mammalian hosts [38].
\nThe human influenza virus threats are derived from avian [21, 39–42] or swine [14, 43] influenza predecessors, but these viruses have adapted to transmit and to replicate in the human host. Highly pathogenic avian influenza H5N1 (HPAIV H5N1) outbreaks during the end of the twentieth century led to lethal disease in domestic poultry and waterfowl, and eventually human intervention was needed to quarantine and cull millions of contaminated flocks worldwide [41, 44, 45]. Although most avian influenza strains typically do not cause disease in humans, HPAIV H5N1 was spread to humans in Hong Kong in 1997. From 2003 to January 2014, the WHO reported 386 human deaths out of the 650 confirmed H5N1 cases [46]. In February 2013, a novel avian influenza virus subtype, H7N9, was also detected in humans [47] and was thought to have arisen from nonpathogenic H7 strains.
\nIn humans, influenza spreads through aerosolized respiratory droplet transmission and the virus attaches to primarily columnar epithelial cells lining the respiratory tract. Infection of influenza spreads to airway epithelial cells [48–50] and alveolar macrophages [51], although dendritic cells [52], natural killer cells [53], and mast cells are semi-permissive for influenza infection in vitro and in vivo. Typical incubation period for influenza virus is 1–4 days, in which an afflicted individual begins shedding virus and continues to shed up to 10 or more days after the onset of symptoms [9, 54]. Unlike human seasonal influenza, most AIV transmits directly from animal-to-human (zoonotic), but infrequently transmits between human hosts; however, since 1918, four influenza pandemics occurred after antigenic shift enabled human adaption and no prior immunity existed in the population. Since influenza hemagglutinin binds to sialic acid receptors that are on respiratory epithelial as well as erythrocytes, a rapid assay for sialic acid receptor binding is the red blood cell agglutination and hemagglutination inhibition (HAI) assays. Developed in the 1940s and based on the ability of influenza hemagglutinin to bind receptors of target cells and agglutinate red blood cells (RBCs), the HAI assay has become the standard serological assay for screening influenza hemagglutinin-reactive antibodies in sera [10]. Serial dilutions of heat-inactivated, receptor-destroying enzyme (RDE)-treated sera are incubated with a fixed amount of virus titrated in hemagglutination units and then RBCs are added to the virus-sera mixture to permit agglutination. The presence of influenza-specific, receptor-binding antibodies prevents RBC agglutination and potentially reduces infectivity. By standard, an antibody titer of >32, or most commonly 40, is correlated with up to 50% protection from influenza disease [14], and seroconversion is assumed when greater than fourfold increase is observed when comparing of pre- and post-vaccination HAI titers [13]. However, as important as the standard agglutination and HAI assays are for vaccine immunogenicity surveillance, new challenges arise when viruses have reduced species-specific RBC agglutination [55, 56] or when HAI titers do not correlate with protection [15]. Consequently, additional verification approaches are needed and applied to assess efficacy beyond immunogenicity of a vaccine candidate; the greatest obstacle, however, is overcoming the antigenic diversity in influenza strains and eliciting vaccine-induced protection prior to antigenic drifts or shifts.
\nInfluenza glycoprotein hemagglutinin (HA) amino acid sequence variation fluctuates rapidly amidst cross-species infections, leading to shifts within HA subtypes. For example, the influenza viruses that spread internationally in 2009 were antigenically unique to seasonal H1N1 strains, but resembled the pandemic H1N1 strains isolated in 1918. The emergence of H1N1 into the human population in 1918 caused the first influenza pandemic of the twentieth century and caused ~50 million deaths worldwide [57]. Cross-reactive antibodies to the pdm H1N1 strains of 2009 were identified in the sera of older people [58] and therefore this implied that people infected with the 1918 H1N1 viruses elicited long-lasting antibodies that cross-reacted with the pdm H1N1 infecting people 90 year later. H3N2 influenza strains emerged in 1968 as a human pathogen after reassortment of HA & PB1 genes with avian source (1918 H1N1 (avian/human)→1957 H2N2 (avian)→1968 H3N2 (avian/human)) [43] leading to the loss of immune recognition among human hosts. The timeline in Figure 1 illustrates the reassortment events that transitioned between avian influenza viruses into human pathogens and the emergence of pdm H1N1 or swine flu remained circulating in the swine population since early twentieth century and was reintroduced in the early 2000s.
\nTimeline of influenza viruses and circulation among avian, swine and human populations.
The emergence of the 1918 Spanish Flu into the human population resulted from divergent reassortment of avian-like influenza and caused substantial morbidity and mortality worldwide. Further reassortment of the HA subsequently led to H2N2 and H3N2, which currently circulates abundantly in the human population. Introduction of H3N2 into the swine population during the 1970s and circulation of H1N2 permitted additional reassortment in the form of novel Swine Flu or pdm H1N1. The recent incidence of avian strains H5N1 and H7N1 is further evidence that zoonotic exchange of influenza viruses increases the likelihood of introduction to human populations.
\nInfluenza HA mediates the binding to host cell surface receptors, dominantly sialic acid, which tends to be specific to species and tissue. HA proteins expressed by avian influenza strains preferentially bind to the sialic acids bound by an alpha 2-3 glycosidic bond, whereas an alpha 2-6 linkage is preferred by human adapted strains. Importantly, the upper human respiratory tract is lined with epithelial cells expressing sialic acids with alpha 2-6, whereas the lower respiratory tract contains sialic acids containing the alpha 2-3[41] potentially increasing susceptibility to lower respiratory tract infections by avian influenza viruses [42]; however, direct droplet transmission between humans is inefficient and remains limited.
\nIn addition to receptor-binding specificity, the influenza HA sequence contains a critical cleavage site that is necessary for initiating pH-dependent fusion into the host cell. Influenza virus HA is synthesized as a precursor HA0, which is composed of a globular surface “head” HA1 and the stalk-like HA2. The HA2 portion contains a transmembrane domain spanning the viral membrane [23, 59, 60]. Within the HA1 subunit is the receptor-binding site (RBS) and a vestigial esterase domain that alters pH stability and ultimately, confers high or moderate pathogenicity [61, 62]. The exposure of the fusion peptide sequence is essential for conformational changes in the coiled-coil trimeric HA structure during a prefusion event, leading to extension of the HA, fold-back, hemifusion and eventual fusion of viral membrane to host membrane [63]. Figure 2 is reprinted from a study [63] that analyzed the fusion event between influenza hemagglutinin and cell membrane of the infected cell, which utilizes a similar coiled-coil hemifusion state as other viral pathogens, such as HIV, respiratory syncytial virus, and Ebola virus [64].
\nFusion event of influenza hemagglutinin on host cell. Adapted from Ivanovic et al. [
Utilizing the coiled-coil motif to extend into a host cell, the hemagglutinin fusion peptide serves as an anchoring “hook” to attach to the cell membrane; through pH-mediated hairpin folding, the hemifusion event occurs, followed by complete fusion of the two membranes and release of viral components into the host cytoplasm.
\nThe majority of low pathogenic influenza strains have HA0 containing a monobasic arginine residue that is cleaved by extracellular enzymes; within the human respiratory tract, the transmembrane protease, serine 2 (TMPRSS2) and human airway trypsin-like protease (HAT) are capable of mediating mono-basic cleavage to yield disulfide-bonded HA1 and HA2 subunits [65]. Several highly pathogenic avian influenza strains (H1N1v, H5 and H7) contain multi-arginine motifs that are cleaved by subtilisin-like cellular proteases and are often present in the intestinal and respiratory tracts of birds and mammals; cleavage by host proteinases, such as furin and PC6, occurs intracelluarly upon exit of the endoplasmic reticulum, and proteolysis is blocked by inhibitors of serine proteases, such as aprotinin [50, 66]. Interestingly, within a human large intestine carcinoma cell line Caco-1, aprotinin treatment and disruption of the late Golgi transport mechanisms by brefeldin A inhibit cleavage of HA0, regardless whether the influenza strain contains mono- or multi-basic proteolytic sites [66]. Figure 3 illustrates the domains HA1 and HA2 in a homotrimer of HA from A/Fujian/411/2002-H3N2 influenza predicted using SWISS-MODEL service [67–70], with antigenic sites highlighted. Sites in H3 HA have been best characterized, with antigenic epitopes defined as A, B, C, D, and E [71–73]. Alternatively, H1 contains five antigenic sites, Cb, Sa, Sb, Ca1, and Ca2, that were originally modeled from H3 structure [74].
\nStructure of influenza hemagglutinin with antigenic sites and domains highlighted.
Influenza hemagglutinin is a homotrimer of a globular head and stalk domains. The HA of A/Fujian/411/2002-H3N2 influenza was modeled to PDB 2yp2.1.a using structure homology software SWISS-MODEL and further manipulated with PyMol. One monomer is shown with surface, whereas the remaining two monomers illustrated in ribbon-cartoon form. Highlighted antigenic sites A (red), B (yellow), C (green), D (blue), and E (purple) are present in H3 HA (shown), whereas Cb, Sa, Sb, Ca1, and Ca2 are the known antigenic epitopes in H1 influenza subtypes. Sites used were derived from 73.
\nIncomplete cleavage of HA0 yields lower viral titers [50, 65, 75] and virions incapable of HA0 cleavage are less infectious upon subsequent replication cycles, with more than 4 log-units lower than cleaved HA [50, 76]. Current cell-based approaches to influenza propagation using Madin-Darby canine kidney (MDCK) cells require artificial addition of trypsin or serine protease treatment to yield appreciable viral titers, but native enzymes in egg-based culture sufficiently cleave HA; therefore, no addition treatment is required [77, 78]; consequently, post-translational HA processing is substantially different between the two standard methods [79]. Recent human isolates, particularly H3N2 subtype, are difficult to propagate in conventional egg or MDCK cell lines; advancements in stable-overexpression of α2–6 sialic acids on the MDCK cell line (MDCK-SIAT1) have improved virus isolation rates[56] and typically retains HA sequence identity better than the aforementioned egg or MDCK approaches. These characteristic of HA and sialic acid binding affinity determine species- and tissue-specificity, and further complicate the likelihood of zoonotic diseases and transmission among humans.
\nFears of an avian HA and NA reassortment with a human seasonal influenza virus are well justified given the emergence of avian-to-human and human-to-human transmissible HPAI H5N1 [45, 80] and subsequent fatality rates averaging 56% [81]. Human infection with H7N9 [47, 82–85] and H10N8 [86, 87] is high risks to individuals working or residing near live poultry markets, and mammalian receptor adaptation remains a significant concern for health officials. While H10N8 does not immediately appear to pose an imminent threat to global health, there are at least 450 confirmed cases of H7N9 by June 2014 since its initial emergence in China in March 2013. Historically associated with a highly pathogenic avian influenza strain, the H7 subtype strains, such as H7N2, H7N3, and H7N7 [47, 88, 89], have the preferential binding to α2–6-linked sialic acids, which increase their affinity to human upper respiratory epithelial cells [88, 90]; however, incidence of H7 avian and rare human infections remained isolated [91]. Experimental aerosol transmission studies in 2012 [92, 93] and 2013 [94, 95] using viruses in subtypes H5 and H7 showed that, similar HPAI H5N1, the H7N9 viruses potentially poses greater threat to humans since it has a limited capacity to transmit through aerosol droplets (REFS) and therefore further investigations are needed to elucidate H7 pathogenesis and HA evolution.
\nThe diversity of influenza virus strains and subtypes exacerbates the challenge for generating a universal vaccine against influenza. The WHO makes recommendations for influenza vaccine composition for each flu season based on international surveillance systems and compares the ability of monovalent vaccine prototypes to elicit cross-reactive antibodies against prevalent circulating strains [16, 96, 97]. Unfortunately, delays in surveillance and the generation and evaluation of serology data hinder the selection of the optimal candidates and seasonal efficacy depends on prompt production by vaccine manufacturers and subsequent distribution. Moreover, the emergence of antigenic drift variants after selection of vaccine candidates may result in poor efficacy and wasted production time and resources [98]. Consequently, there is a demand for a universal, or more broadly reactive, vaccine against influenza virus. Utilizing various manufacturing platforms, adjuvants, and targets, researchers worldwide are currently seeking ways to improve current influenza vaccination strategies [99]. The following traits are desired in an ideal universal vaccine candidate: [1] recognition of antigenic drift variants; [2] elicitation of long-lasting memory responses; and [3] minimal manufacturing lag time between vaccine formulations. Additional desirable features may include cost-efficient production methods, predictive measures to protect against future antigenic variants, and efficacy among immunocompromised target populations, infants and elderly over the age of 65. Despite nearly a century of research, human influenza vaccine production is largely based on the traditional technologies. The rapid emergence of antigenically unique subtypes continues to challenge the current pace of diagnosis, prototype selection, and egg-based vaccine distribution. Furthermore, the importance of pre-existing immunity determines the level of protection from novel strains and depends on the presence of circulating cross-reactive antibodies. For example, individuals born prior to 1957 reportedly had fewer complications associated with pdm H1N1 than the younger, naïve population potentially because the elderly population encountered similar historical H1N1 strains during their lifetime and therefore had pre-existing neutralizing antibodies to antigenically similar strains [100].
\nCommon name | \nDistributor | \nInactivation | \nDetergent | \nPlatform | \nDerived from: | \nRef | \n
---|---|---|---|---|---|---|
CSL Limited | \nbeta-propiolactone | \nsodium taurodeoxycholate | \nSplit virus | \nEmbroynated chicken eggs | \n[110] | \n|
GlaxoSmithKline | \nformaldehyde | \nsodium deoxycholate | \nSplit virus | \nEmbroynated chicken eggs | \n[111] | \n|
ID Biomedical Corporation of Quebec (GSK) | \nUV, formaldehyde | \nsodium deoxycholate | \nSplit virus | \nEmbroynated chicken eggs | \n[112] | \n|
CSL Limited (Formerly Novartis Vaccines) | \nbeta-propiolactone | \nnonylphenol ethoxylate | \nSubunit | \nEmbroynated chicken eggs | \n[114] | \n|
Sanofi Pasteur | \nformaldehyde | \nTriton X-100 | \nSplit virus | \nEmbroynated chicken eggs | \n\n | |
CSL Limited (Formerly Novartis Vaccines) | \nbeta-propiolactone | \nCetyltrimethylammonium bromide | \nSubunit | \nMDCK mammalian cells | \n[115] | \n|
Sanofi Pasteur | \nformaldehyde | \nTriton X-100 | \nSplit virus | \nEmbroynated chicken eggs | \n[116] | \n|
MedImmune | \nN/A-cold-adapted, temperaturesensitive, or attenuated | \n\n | Live reassortant | \nEmbroynated chicken eggs | \n[117] | \n|
Protein Sciences | \nnone-purified HA | \nTriton X-100 | \nRecombinant HA | \nexpresSF+ insect cells | \n[118] | \n|
Seqirus™ (CSL Limited) | \nformaldehyde | \nCetyltrimethylammonium bromide | \nSplit virus, MF59C.1 | \nEmbroynated chicken eggs | \n\n |
A list of FDA-approved influenza vaccines in US market as of March 2016.
In contrast, recent evidence suggests that sequential exposure to seasonal strains confers greater protection against novel antigenic drift variants; consequently, the question remains whether the existence of protective neutralizing antibodies in the elderly is due to immunological recall, or rather, enhanced broadly reactive response due to immunological boosts of heterologous strains over a lifetime. This has since been modeled in the ferret animal models and, without prior exposure to the pdm H1N1, ferrets sequentially challenged with seasonal H1N1 [101, 102] or immunized with inactivated seasonal vaccine [103] strains mount protective responses to pdm H1N1. In summary, seroprotection against influenza may also depend on the individual’s pre-existing immunity, as well as the platform and strategy implemented.
\n\x3c!--\n | \n
A list of FDA-approved influenza vaccines in US market as of March 2016.
\nCurrent 2016–2017 influenza vaccines recommended by the WHO are available as an inactivated trivalent or quadrivalent formulation delivered intramuscularly or as live attenuated mixture of influenza strains (LAIV) administered through intranasal route [104]. The various doses and formulations may or may not contain ovalbumin or mercury, and eligibility for some formulations is age restricted. Vaccine manufacturers have proprietary methods for virus propagation and inactivation, which often alters the antigenic properties of the vaccine candidate. Vaccine antigens may be prepared as whole virus, detergent or solvent disrupted split virions [105, 106], or subunit vaccines [107–109]. Table 1 displays the 2016–2017 FDA-approved influenza vaccines used in the United States and exhibits formulation differences as described in the package inserts of each product [110–118]. Essentially, all current formulations aim to elicit protective antibody responses, predominantly against HA, and therefore protect against antigenically similar viral strains to the vaccine strain. Since the vaccine is often generated as a reassortant (6:2) vaccine strain from a high yield genetic backbone A/Puerto Rico/8/34 (H1N1), the HA and NA selected as a seasonal vaccine recommendation must be reformulated each season and validated for cross-reactivity to antigenically similar strains using HAI assay [98].
\n\nAdverse reactogenicity remains a safety concern for the young, immunocompromised, and elderly, therefore split or subunit vaccines are preferred over live or whole inactivated virus, despite enhanced humoral responses elicited by whole virus preparations [119]. Efforts to reduce the risks associated with LAIV are particularly important since humoral and cross-reactive T-cell responses are superior to that of inactivated vaccines in experimental swine and ferret studies [120–122]; among children, LAIV, but not inactivated vaccine, led to enhanced CD4+, CD8+, and γδ T-cell responses [123]. In contrast to inactivated vaccines that require reformulation each year, there is evidence that LAIV induces cross-reactivity with heterologous strains. This cross-reactivity phenomenon makes LAIV a promising candidate for the development of a universal vaccine platform. The route of administration, absence of active viral replication, and process of inactivation are different between influenza vaccine formulations. Further studies are needed to understand the mechanisms that promote influenza-specific T-cell responses upon LAIV immunization.
\nThe WHO recommends propagating influenza viruses in embryonic chicken eggs, and this methodology is predominant source of high yield vaccine strains [124]. A list of FDA-approved influenza vaccines, majority of which are derived from embryonated chicken eggs, is provided in Table 1.
\nTable 1 shows differences in inactivation, detergents, and platforms used in the current vaccine market.
\nDespite the frequent use of the relatively inexpensive but highly productive virus production egg-based platform, some challenges are arising. Spontaneous mutations due to egg adaptation were recognized as early as 1951 [125] and, as a recent vaccine efficacy (VE) study showed, may present unanticipated challenges to vaccine development. In the 2012–2013 influenza season, MDCK-grown prototypes were selected for vaccine production and classical reassortant methodology was performed; in brief, co-culture of high-yield A/Puerto Rico/8/34 (H1N1) reassortant (6:2) with the HA and NA gene products from A/Victoria/361/2011 (H3N2) in the presence of antiserum to A/Puerto Rico/8/34 yielded reassortant A/Victoria/361/2011(H3N2)-IVR-165 [126]. During vaccine production, the high growth strain acquired several substitutions within the antigenic site B, which reduced reactogenicity against the original prototype A/Victoria/361/2011 and antigenically similar circulating field strains, resulting in a disappointing 39% (95% CI, 29%–47%) rate in humans vaccinated with the 2012–2013 egg-based preparations [127]. Consequently, the low VE for the 2012–2013 H3N2 season is attributed to changes in the HA due to vaccine manufacturing, not antigenic drift. In contrast, growth in mammalian cell lines results in fewer mutations than in eggs, with up to two mutations in the hemagglutinin of H3N2 strains after three passages in MDCK [128–130] or MDCK-SIAT1 [56] but no genotypic changes reported after 10 passages of avian influenza using human colorectal adenocarcinoma cell line, Caco-2 [131]. These examples suggest that alternative methods for influenza propagation are expanding and optimization could ensure more consistency and efficacy.
\nIn 2013, the FDA approved the first MDCK cell-culture influenza vaccine (CCIV) called Flucelvax®, originally developed by Novartis Vaccines and Diagnostics, Inc., Cambridge, MA, USA [115] but acquired by CSL Limited, Melbourne, Australia, as of December 2015 [132], which is tolerable and safe, and demonstrates comparable, if not greater, protection to that of traditional egg-based technologies [133–137]. Furthermore, trials involving trivalent preparation of influenza viruses through growth in green monkey kidney cell line, Vero, is another new alternative to egg-based propagation [138]. Although not yet FDA approved in the United States, the Vero cell-based technology licensed as Vepacel® from Baxter AG, Vienna, Austria, is a pre-pandemic whole, inactivated virus H5N1 vaccine designed to elicit strong immunological responses in healthy, as well as immunocompromised populations [139]. Also in 2013, the FDA approved a recombinant HA (rHA) only influenza vaccine (Flubok®) from Protein Sciences Corporation, Meriden, CT, USA [118]. Flubok is generated from insect cells using a baculovirus expression system to produce high yield rHA vaccine against each seasonal influenza subtype. Further studies are still needed to assess cost-effectiveness in transitioning the current platforms of egg-derived influenza virus to mammalian cell culture. Modifications to standard method of virus propagation have economical and practical challenges, but federal initiatives suggest divergence from traditional egg-based approaches.
\nA disadvantage of mammalian cell culture is the need for regulated growth conditions and reagents, which hinder immediate production and increase cost; however, advancements in high-throughput bioreactors are ongoing [140]. However, the same types of technologies involved in mammalian cell culture virus propagation may further advance novel alternatives to eggs. Virus-like particles (VLPs) are non-replicating, self-assembling nanostructures that mimic virus surface protein presentation and are synthesized through co-expression of recombinant DNA in insect or mammalian cell culture [141–147]. Multiple advantages are associated with VLP over standard methods [141], including [1] they are non-infectious material and therefore not a biohazard risk and inactivation is not required, [2] VLPs self-assemble into proper conformation and multivalency, and [3] influenza VLPs have enhanced stability and HA potency up to 12 months with no degradation [148]. Several investigators have utilized this platform for evaluating immunogenicity of influenza HA [149–151], NA [144], M2 [152], and combinations of viral proteins. A mammalian VLP derived in Vero cells, H5N1-VLP (RG-14) [153], was composed of four influenza virus structural proteins and protected against a lethal H5N1 challenge in mice, yielding H5-specific IgG1 antibodies with a dose as low as 2.5 μg in a prime-boost regimen. Similarly, baculovirus-derived VLPs expressing H3N2 protected against a lethal challenge of mouse-adapted influenza H3N2 A/Hong Kong/68 [149], with intranasal instillation providing the greatest HA-specific antibody titers and protection as compared to intramuscular administration or two doses of sublethal intranasal challenges. The baculovirus/insect cell expression systems generate high yields of VLPs, and trivalent vaccine preclinical studies in mice and ferrets demonstrate the baculovirus-derived VLPs effectively elicit serum HAI antibodies against H1N1, H3N2, and influenza B, although cross-reactivity to heterologous strains was poor [154]. Importantly, side-by-side comparison of baculovirus-derived VLPs versus whole virion vaccine or recombinant HA suggests VLPs elicit comparable, if not higher, IgG titers, but also yielded antibodies that cross-react to a broader panel of non-homologous influenza viruses [146]. The baculovirus-derived VLPs have been fully characterized by Novavax , Inc. from Rockville, MD, USA, for the HA content, NA activity, stability, and VLP purity [155], and safety and reactogenicity were evaluated in two clinical trials with H5N1 and H1N1 baculovirus-derived VLPs [156, 157].
\nProprietary application of recombinant RNA bacteriophage Qbeta by Cytos Biotechnology Ltd., Switzerland, offers an alternative strategy for conformational antigen presentation on the surface of Qbeta-derived virus-like particles through covalent chemical linkage [158]. Since presentation on Qbeta-derived VLPs does not involve post-translational modifications from the VLP-producing cell, potential cell type-specific alterations to the viral surface glycoprotein are avoided [159]; moreover, chemical linkage of antigens to Qbeta-derived VLPs overcomes the steric hindrance associated with masked immunodominant epitopes and efficiently elicits B cell responses in the absence of an adjuvant [160]. Importantly, specific sites or domains can be exclusively presented on the Qbeta-VLPs, such as the globular head of influenza hemagglutinin to induce hemagglutination inhibiting antibodies [161]. Consequently, this approach advanced to Phase I clinical trial in Singapore through sponsorship of the manufacturer Cytos Biotechnology; the findings suggest that the Qbeta-VLP is tolerable and elicits HAI-specific antibodies comparable to the standard influenza vaccines [162]. However, as with any new approach, insect-, mammalian-, or Qbeta-VLP manufacturing processes still need to undergo more thorough safety evaluation and quality control; therefore, marketing and production are still a few years away.
\n\nModern recombinant technology offers alternatives to live virus preparation. Synthetic or subunit viral peptide vaccines stimulate the immune response in similar mechanism as split inactivated vaccines and may be formulated with pattern recognition receptor agonists or emulsions to enhance adjuvant activity. Plasmid DNA encoding an immunogenic viral protein can be electroporated [163], administered intranasally in conjugation with nanoparticles [164], or delivered with a biolistic system. Particle-mediated epidermal delivery of DNA encoding influenza HA was recently optimized in an experimental ferret model and, when administered to the abdomen or tongue, yielded HAI titers greater than 1:40 [165]; sublingual route of vaccine administration has potential to elicit mucosal immunity and mount protective secretory immunoglobulin A (sIgA) [166, 167]. Previously in preclinical studies, delivery of recombinant IgA protects against infection in the experimental animal influenza model [168] while elicitation of IgG controls disease severity, thus elicitation of IgA by any universal vaccine candidate would be highly beneficial. In the effort to reduce infant morbidity associated with influenza infections, ongoing studies will test the safety, efficacy, and tolerability of vaccination of pregnant mothers and their newborns [169–171]; subsequent protection through maternal IgG and sIgA lasting up to 6 months could reduce infection within influenza virus [172].
\n\x3c!--\n | \n
Clinical trials ongoing the US testing novel influenza vaccine or antiviral approaches.
\nIn addition to the HA, DNA vaccination of the neuraminidase N1 from H1N1, A/New Caledonia/20/99, also partially protects against heterologous challenge with H5N1, A/Vietnam/1203/04, in the mouse model; similarly, passive immunization of heterologous anti-N1 sera in naïve mice provided modest protection against H5N1 challenge [173]. NA-DNA vaccination also conferred crossprotection against heterologous H3N2 strains in a lethal H3N2 influenza challenge [174], further suggesting neuraminidase may be an additional target for eliciting protection against drift variants within a influenza subtype. In addition to the neuraminidase, viral targets such as the nucleoprotein (NP), matrix 1 and 2 (M1 and M2), and polymerase (PB1) are different immunogens for vaccine candidates, resulting in varied immunological responses. Internal NP is the predominant target antigen for cytotoxic T lymphocyte (CTL) activity and is well conserved among influenza A viruses; peptide-based and DNA vaccination strategies have demonstrated promising protection against homologous and heterologous challenge with influenza A viruses. However, as with epitope-specific T cell responses, binding and affinity between epitope and human leukocyte antigen (HLA) could be restricted to highly polymorphic HLA alleles and could reduce efficacy among particular populations [175]. Consequently, promiscuous T cell epitopes that bind sufficiently to a wide range of HLA alleles remain to be identified. Recent studies also suggest cooperative T helper cell assistance to mount B cell immunological responses to promiscuous epitopes on the ectodomain of M2 protein, M2e [176]. Modified M2e, termed M2e multiple antigenic peptides (M2e-MAPs), appears to protect against influenza challenges among mice of various genetic background, providing proof of concept that M2e-MAPs are not necessarily MHC allele-restricted. Multiple efforts remain ongoing to test the feasibility of M2e-MAP-based vaccine strategies against influenza.
\nClinical Trials | \nImmunogen | \nPrinciple | \nImmune response target | \nPhase | \nClinicalT rials.g ov ID | \nSponsor | \nRoute | \nRef | \n
---|---|---|---|---|---|---|---|---|
Adjuvanted recombinant antigen | \nM2e fused to TLR5 ligand S. typhimurium flagellin | \nM2e | \n1, 2 | \nNCT00603811 ; NCT00921947 | \nVaxInnate Corporation | \nI.M. & S.C. | \n\n | |
Viral Vector | \nAttenuated vaccina virus prime-boost regimen | \nNP and M1 | \n1 | \nNCT00993083 ; NCT00942071 | \nUniversity of Oxford | \nI.D. | \n[177] | \n|
Viral vector | \nAttenuated adenoviral and vaccinia virus prime-boost regimen | \nNP and M1 | \n1 | \nNCT01818362 | \nUniversity of Oxford | \nI.M & I.M. | \n\n | |
Synthetic polypeptides | \nLyophilized polypeptides T- cell epitopes | \nM1, M2, NP and PB1 | \n1 | \nNCT01181336 | \nPepTcell Limited | \nS.C | \n\n | |
Recombinant antigen | \nRecombinant M2e | \nM2e | \n1 | \nNCT00819013 | \nSanofi | \nI.M. | \n\n | |
Reassortant, inactivated influenza virosome | \nA/Vietnam/1194/2004 (H5N1) and A/Puerto Rico/8/34 (H1N1) (PR8) with alum or ISCOM-like Matrix M™ adjuvant | \nHA (Head/Stalk) | \n1, 2 | \nNCT00660257 ; NCT00535665 | \nSinovac Biotech Co., Ltd | \nI.M. | \n[150], [151] | \n|
Baculovirus VLP | \nA/Indonesia/05/2005 VLP | \nHA, NA, and M1 | \n1,2 | \nNCT00519389 | \nNovavax | \nI.M. | \n[157] | \n|
Baculovirus VLP | \nA/California/07/2009 VLP | \nHA, NA, and M2 | \n1,2 | \n\n | Novavax | \nI.M. | \n[158] | \n|
Qbeta VLPs | \nA/California/07/2009 VLP | \nHA | \n1 | \nCIRB Ref: 2012/906/E | \nCytos Biotech. | \nI.M. | \n[163] | \n
Clinical trials ongoing the US testing novel influenza vaccine or antiviral approaches.
Since monovalent HA reactivity is thought to limit broad use of an influenza vaccine, alternative strategies aimed at less conventional tactics aside from full-length, wild-type HA. Directed reactogencity to either the globular head or stalk have been examined in mice, ferrets, and human clinical studies [150, 151, 156]. Broad protection against heterologous influenza virus strains is thought to rely on elicitation of well-conserved, HA2, stalk- or stem-specific antibodies [177]. Cross-protection against heterologous strains and crossreactivity to various subtypes appears the most rational direction toward a universal influenza vaccine. Immunization with recombinant HA2 construct that maintains a neutral pH conformation conferred protection against homologous H3-type virus strains, such as A/Philadelphia/2/82 and A/HK/68, but not heterologous H1-type viruses [178]. Importantly, prime-boost immunization of chimeric hemagglutinin expressing mismatched globular HA heads on homologous HA stalk (cH6/1, cH9/1, and cH5/1) elicited stalk-reactive, neutralizing antibodies and conferred protection against lethal H1N1challenge [179]. Protection, however, remained limited within a particular influenza group; therefore, further investigation remains to overcome such large diversity of influenza viruses. In an attempt to address the vast diversity of globular HA, computationally optimized broadly reactive antigens (COBRA) have been utilized in mammalian VLP platforms against H5N1 infection in mice, ferrets, and nonhuman primates [180–182]. Through multiple layers of consensus sequences of influenza hemagglutinin, COBRA methodology avoids database input bias associated with influenza surveillance systems; constructs generated have been validated to stimulate greater immunological breadth than monovalent vaccine strategies while successfully eliciting seroconversion, yielding hemagglutination-inhibiting antibody titers more than fourfold. Table 2 is a summary of several clinical trials that investigated novel influenza vaccine strategies with various targets and approaches for eliciting protective immunity. In conclusion, the efficacy of the immunogen, route of administration, and types of immune responses elicited will further determine whether novel approaches could replace current vaccination methods.
\n\nThe ClinicalTrial.gov database provides latest information regarding past and current clinical trials and the status toward future applications. Unlike the conventional influenza vaccines that dominant to HA-mediated immune responses, recent clinical trials test antiviral therapies targeting influenza matrix (M and M2e, matrix ectodomain) or highly conserved nucleoprotein (NP). These strategies come from various technologies, including virus-like particles (VLPs) and platforms, which do not rely on the egg-based vaccine manufacturing processes. The routes of delivery also vary, including intramuscular (IM), intradermal (ID), and subcutaneous (SC).
\n\nThe pursuit of a universal vaccine against influenza is a constant battle between influenza virus evolution and current technologies. Since influenza infections remain ubiquitous among humans, as well as wildlife and domestic livestock, reassortment of genomic segments can still yield combinations that the human species has not previously encountered; alternatively, gradual antigenic variation of the hemagglutinin also results in poor cross-reactivity and protection against heterologous strains. As such, protective measures such as effective vaccination and more thorough understanding of HA evolution are needed to prevent forthcoming pandemics. Current practices rely on relatively traditional technologies for vaccine selection and manufacturing, and as witnessed during the pandemic H1N1 outbreak of 2009, it took months to identify and manufacture a new vaccine [183, 184]. In addition, inadequate quality control led to sterility breaches of millions of doses Fluvirin®, which at-time was manufactured by Chiron, acquired first by Novartis Vaccines and Diagnostics Limited, Speke, Liverpool, UK [185, 186] but now recently under Seqirus™, a CSL Limited company. During such shortages, it was evident that influenza vaccine resources were insufficient given the substantial health risks. To minimize future damages, both in morbidity and economical losses, the international community must disseminate new findings rapidly and cooperatively strive for more effective and readily available preventative actions.
\nIn addition to the current vaccine approaches, innovative strategies are being tested for feasibility, safety, and the elicitation of broad immunogenicity to influenza strains and subtypes. Overcoming the antigenic diversity remains the greatest challenge to the efforts of designing a universal influenza vaccine. Moreover, changes in manufacturing and rapid implementation are critical for vaccine efficacy and may require divergence from the currently accepted methodologies. The recombinant technology and nonconventional vaccine platforms aforementioned demonstrate potential and may rival the current standard of care. As our understanding of immune responses to influenza and antigenic variability furthers, improvements to influenza vaccine strategies are expected to prevent significant morbidity and unnecessary disease through preventative measures.
\nSince the ultrafast (femtosecond) laser was demonstrated in the 1980s, the field of terahertz (THz) technologies has emerged with an array of applications appearing in different areas, from spectroscopy and sensing to imaging and high-speed communications [1, 2]. Terahertz radiation is nonionizing radiation and has low photon energies, thus having less chance of tissues, cells, and DNA damage during the spectroscopic, sensing, and imaging applications. In addition, the terahertz radiation can be transmitted through some opaque objects in visible light, which opens an array of detection and security applications. The late development of the THz applications is due to the challenges in the generation and detection within the THz band. Its frequencies of 0.1 to 10 THz (30 μm to 3 mm), sandwiched between the electronic and optical frequencies, cannot be generated by conventional electronics or optical methods [3]. This is because the conventional electronics technologies are insufficient to produce broadband waves at these relatively high frequencies. On the other hand, conventional optical technologies cannot emit THz frequencies due to a fundamental issue; there is no material with a bandgap energy corresponding to the THz frequencies [4]. Fortunately, various ultrafast laser and semiconductors approaches have been examined and established. That leads to demonstration of the first emission of pulsed THz radiation using a dipole photoconductive antenna in 1988 by Smith
The photoconductive THz emitter is an optoelectronic device with three main components, being the photoconductive materials, the photoconductive electrodes, and the lens [8] (Figure 1). The photoconductive material is a semiconductor having bandgap energy compatible with the photon energy of the ultrashort laser pulses. In addition, the photoconductive material should have optimum characteristics, including carrier lifetime, carrier mobility, breakdown voltage, and dark resistivity [9]. The carrier lifetime is preferable to be short. However, in the case of the photoconductive detector, it must be in the subpicosecond range. A higher breakdown voltage, carrier mobility, and dark resistivity are fundamental characteristics to assure a better photoconductive THz emitter performance in the form of higher radiated power, higher SNR, and broader bandwidth. The second component is the photoconductive electrodes. The photoconductive electrodes are two metal electrodes patterned on top of the device, having a gap in between, namely, a photoconductive gap. The design and dimensions of such a gap will influence the device’s performance. The last component is the lens. The lens is typically integrated with the emitter to accumulate the radiated field; the radiated field will then be focused on the targeted radiation path.
Illustration of the photoconductive device, as in (a) it shows a schematic diagram of the photoconductive THz emitter, and in (b) it shows the semiconductor band structure under the applied electric field. © IOP publishing. Reproduced with permission. All rights reserved [
The photoconductive THz emitter can generate the THz radiation following photoexcitation of its photoconductive gap by an ultrashort laser pulse. When the laser pulse is focused into a photoconductive gap, the laser pulse generates free electrons and holes within the semiconductor, having a rate proportional to the laser pulse [10]. The free carriers will then accelerate under a bias field, controlled by the bias voltage,
This chapter presents the photoconductive devices for THz generation, with insights into their components, limitations, and considerations, and recent progress in this field. In Section 2, a number of photoconductive materials are discussed, the influence of the material and material’s characteristics are addressed. In Section 3, the photoconductive electrodes (structure) are considered. This includes different structures characteristics based on their size, being a large aperture antenna, a small aperture antenna, and the plasmonic antenna, discussing the influences on the photoconductive THz emitters’ performance. In Section 4, the limitations of the THz emission by photoconductive devices are discussed. The presented limitations are mainly related to the bias field and optical (pump) fluence, which appear in the form of radiated power saturation. In addition, the underlying physics of the space charge and near-field saturation is provided. Ultimately, in Section 5, the recent advances in photoconductive devices technology are given, including the integrated devices and the system-on-chip technologies.
In general, the photoconductive THz emitter performance differs based on the photoconductive material and structure. Therefore, the photoconductive material will be the focus of this section. The optimum photoconductive materials would be crystal lattices with a direct bandgap between the valence and conduction bands. This bandgap determined the absorption wavelength of the exciting laser pulse. Other factors that play a significant role in choosing suitable materials are low carrier lifetime and high carrier mobilities. The most studied materials for photoconductive devices are gallium arsenide (GaAs), indium gallium arsenide (InGaAs), quantum well of InGaAs, indium aluminum arsenide (InAlAs), and a combination of group III-VI materials. This section will explore the photoconductive materials GaAs, ion-implantation in GaAs, InGaAs, and multi-quantum wells InGaAs/InAlAs.
Gallium Arsenide (GaAs) is a III–V semiconductor that has a bandgap of (Eg ∼ 1.42 eV at 300 K) corresponding to the emission wavelength of 880 nm [12]. GaAs is compatible with the titanium-doped sapphire (Ti: sapphire) femtosecond pulsed laser sources typically used to illuminate the photoconductive THz emitters. The GaAs has been the most common material and is typically employed in semi-insulating (SI)-GaAs, low temperature-grown (LT)-GaAs, or ion-implanted GaAs. The SI-GaAs grown by liquid-encapsulated Czochralski at 450–600°C [13] is typically a single crystal that has a high resistivity (>107 Ω cm) and a high electron mobility (μ > 7000 cm2/Vs) [14]. The SI-GaAs is considered a cost-effective substrate and has become widely used material for photoconductive devices. However, the research was ongoing to shorten the carrier lifetime. The LT-GaAs grown on SI-GaAs is proved to reduce carrier lifetime two orders of magnitude to below 1 ps compared to SI-GaAs (t > 100 ps) and efficiently generate broadband THz radiations of over 1 THz with high resistivity (107 Ω cm) and reasonable mobility μ (100–300 cm2/Vs) [15]. The growth is typically done by molecular beam epitaxy (MBE) on the surface of SI-GaAs substrate and growth temperature to between 200°C and 300°C in an arsenic-rich environment [16]. In such a case, it yields a high level of crystallinity, which means higher carrier mobilities and point defects due to excess As precipitants. Higher mobility leads to fast response, and point defects significantly reduce the lifetime (below 400 fs). These point defects act as recombination centers [15]. Increasing the temperature above 250°C will increase the lifetime to be greater than 50 ps. Tani
An alternative approach is using the ion-implantation technique to create point defects and reduce the lifetime in SI-GaAs by implementing arsenic, oxygen, nitrogen, carbon, and hydrogen (proton). Implanting H+ ions are shown to decrease the carrier lifetime of GaAs to sub-picosecond. Then several groups studied the effect of As+3 ion implantation of SI-GaAs and introduced excess As+3 impurities within the crystal structure similar to LT-GaAs [11]. However, the ion-implantation technique of As+3 (GaAs∶ As+3) improved the controllability of the excess As+3 concentration and uniformity as compared to LT-GaAs, making it more reproducible than LT growth [11]. Salem
The InGaAs are also employed as photoconductive material. It is a great advantage of the III-V compound to engineer the bandgap by changing the composition ratio. For example, the bandgap of the ternary compound indium gallium arsenide (InxGax-1As) can be potentially varied from 1.42 eV (x = 0) to 0.36 eV (x = 1). From a practical point of view, the protentional to achieve 0.8 eV (1550 nm optical excitation) was the motivation for investigating this material for THz applications. Doping InGaAs by iron has been demonstrated to provide required recombination sites for a subpicosecond carrier lifetime, higher optical pump saturation power, and higher breakdown voltage. Wood
Heterostructure devices consisting of alternate InGaAs/InAlAs multilayer stacks (multiquantum wells) have been proposed [21] as potential materials for photoconductive devices and achieve high performance at 1550 nm comparable to LT-GaAs excited at 800 nm. Sartorius
In addition to the GaAs, and InGa(Al)As, many other materials of group III-V such as InAs [23], InSb [23], GaSb [24], GaAsSb [25], and doped InGaAs [26], GaInSb [25] are studied as photoconductive material. Choosing the materials highly depends on the application and operating wavelength. Although LT-GaAs is still the most used material for photoconductive devices and is the most efficient material for 800 nm. However, it exhibits poor absorption at 1.55 μm, where other materials such as InGaAs or InGaAs/InAlAs heterostructure become more attractive. Table 1 summarized some of the photoconductive materials with the advantages, disadvantages, active layer, and the operating wavelength.
Photoconductive material | Advantages | Disadvantages | Active layer | Operating wavelength (nm) |
---|---|---|---|---|
GaAS | The most used materials for THz PCAs and is well studied. It is the most efficient material for 800 nm. | It is not suitable for 1550 nm excitation wavelength. | LT-GaAs | 780 |
LT-GaAs | 770 | |||
LT-GaAs | 776 | |||
LT-GaAs | 800 | |||
SI-GaAs | 800 | |||
GaAs:Er | 1550 | |||
InGaAs | Suitable for 1550 nm excitation wavelength. | Low dark resistivity. | InGaAs | 1550 |
InGaAs | 1550 | |||
Multi-QW | Higher dark resistivity. High performance at 1550 nm comparable to LT-GaAs excited at 800 nm. | More complication. | InGaAs/InAlAs | 1550 |
other materials of group III-V | The ability to engineer the target excitation wavelength. | More complication. It is not well studied. | InAs | 780/ 1550 |
InSb | 780/ 1550 | |||
GaSb | 800 | |||
GaAsSb | 800 (up to 1440) | |||
InGaAs | 800 and 1500 | |||
GaInSb | 800 |
Summary of some photoconductive materials with the advantages, disadvantages, active layer, and the operating wavelength.
The photoconductive devices for THz emission have been developed extensively to fulfill the demand for high-performance THz emitters—and thus be essential for spectroscopic and imaging applications. The development of the emitters’ structure is related to its design and dimensions and how that is attributed to the high performance of the THz emission. The performance of the photoconductive THz emitters is determined in the form of radiated power (or the THz spectral amplitude), SNR, and bandwidth. It is worth noting that the bandwidth here manifests itself as is the maximum frequency in the THz spectral amplitude, as a function of frequency,
In the large-aperture and interdigitated electrodes photoconductive THz emitters, the gap between the two electrodes can be large as 4 mm to 130 μm [11]. Such a gap will allow a high level of optical excitation before reaching the saturation issues. Thus, the importance of such emitters stems from the need to scale up the radiated power, which is influenced by the incident optical power. A molded has been developed by Darrow
In the small-aperture photoconductive THz emitter (dipole antenna), the gap between the two electrodes is smaller than in the large-aperture THz emitters, typically below 200 μm. In this case, it will be more difficult to align the laser spot within the PC gap. Although these emitters experience the saturation issues at lower pump fluence, in comparison with the large-aperture THz emitters, these emitters provide broader bandwidth over the large-aperture THz emitters. Our recent work on the design and structure of photoconductive THz emitters based on SI-GaAs examined the influence of bowtie structure characteristics on the THz spectral amplitude and bandwidth [28]. It is found that the bandwidth can be improved from 3.4 THz to 3.7 THz by changing the design of electrode structure from a sharp bowtie to an asymmetric bowtie structure at the same photoconductive gap. That could be attributed to the smaller capacitance of the sharp bowtie structure over the asymmetric bowtie structure, which results in a shorter resistance-capacitance (RC) time constant. The RC time constant,
Figure 2 illustrates the biased photoconductive gap with its equivalent circuit, here the redistribution of charge on the electrodes, can be seen as incident voltage waveform,
A biased photoconductive gap at bias voltage,
The plasmonic THz emitter is introduced by Berry
A schematic diagram of the photoconductive device shows in (a), the conventional photoconductive THz emitter, and in (b), the plasmonic photoconductive THz emitter. © IOP publishing. Reproduced with permission. All rights reserved [
Overall, the photoconductive structure plays a significant role in the performance of the photoconductive THz emitters. The large-aperture and interdigitated electrodes THz emitters mitigate the influence of saturation for scaling up the THz emission with the optical influence. The small aperture THz emitter (dipole antenna) shows a broader bandwidth, which allows discovering a more comprehensive range of THz frequencies. In addition, the recent studies on plasmonic devices present their significance to the photoconductive THz emitter performance. It also steers the future research and development of high-performance photoconductive devices for spectroscopy, sensing, and imaging applications.
The underlying physics of the THz emission by photoconductive devices is the core of this section, which helps understand these devices’ behavior. The photoconductive THz emission scales linearly with the applied bias field and pump fluence. However, that can be precise only in the ideal case, at low levels of bias field and/or optical excitation. Higher levels of bias field influence the photoconductive THz emitters’ performance. Such influence can be seen as thermal effects, space-charge-limited current effects, etc. In addition, the photoconductive device has a limitation at a higher bias field correlated to the breakdown voltage of the photoconductive material. The pump fluence also has an impact, but that can be observed as the saturation of the THz radiation. The saturation (screening) of the THz radiation is mainly associated with two different mechanisms, being space-charge and near-field screening. This section will explore the limitation of the photoconductive THz emission with insights into the material and structure implications on photoconductive THz emitter’s performance.
The THz radiated power (or the THz field amplitude,
The scaling of THz radiated power as the THz field amplitude,
The pump fluence impacts the radiated THz power in the form of saturation (screening). At a higher level of optical excitation, the radiated THz power will be saturated. This saturation can be classified into two mechanisms, being space-charge and near-field screening. However, each screening status differs based on the photoconductive characteristics (material and structure) and optical characteristics (pump fluence). It is worth noting that transient mobility (mobility as a function of pump fluence) plays an important role in the emitted THz power and thus in the screening of the THz field [30]. The mechanisms of these two screening effects are explained in the next paragraph.
In the space-charge THz screening, the limitation of the photocurrent within the photoconductive gap is due to the high carrier densities within the photoconductive gap, affected by the high pump fluence. The charges drift in the opposite direction. Thus, the bias field screens and ultimately limits the radiated THz field [36]. In the near-field THz screening, the direction of the radiated THz field is in the opposite direction of the bias field, which limits the linear scale of the THz radiated field with the pump fluence, as increasing the pump fluence will raise the carrier densities within the semiconductor [37]. At the same pump fluence, the carrier densities in the emitter with a large photoconductive gap will be smaller than in the emitters with a small photoconductive gap. Thus, a large photoconductive gap emitter leads to scaling up the radiated THz power for higher levels, which increases the total emitter performance, before reaching the screening issues [30].
Overall, the main limitations of the THz emission by photoconductive devices can be related to the applied bias field and the exciting pump fluence. The two limitations are correlated with the photoconductive material and structure characteristics. These two limitations prevent the THz field amplitude from scaling linearly with the bias field and pump fluence. Thus, it is essential to design the photoconductive THz emitter carefully. Furthermore, the photoconductive material must be chosen judiciously to meet the demand of the high-radiated THz field for the aforementioned advanced applications.
A number of the recent advances and research in the field of photoconductive devices are discussed in this section, with insight on the development of the material and structure to enhance the photoconductive THz emission for spectroscopic, sensing, and imaging applications. The section will explore different approaches including:
Quantum dots.
Nanostructured electrodes (non-plasmonic) of the photoconductive device.
Dielectric metasurfaces in photoconductive terahertz devices.
Grating photoconductive devices.
The development of the photoconductive THz emission using such new approaches is notable. The quantum dots are mainly related to photoconductive materials. In contrast, the nanostructured electrodes, dielectric metasurfaces, and Grating photoconductive devices are associated with the photoconductive structure. Here, the main interest is to focus on improving the THz emission using these different approaches and the potential enhancement of these devices.
The quantum dots have been employed to boost the photoconductive THz emitters’ performance. Gorodetsky
Nanostructure electrodes of the photoconductive device show an improvement of the photoconductive THz generation, even without a plasmonic effect. Although the plasmonic photoconductive THz emitter is one of the breakings through in the THz generation and detection field, the nanostructure has its encasement on the performance of such devices [41]. Singh et al. examined an antenna nanostructure fabricated by utilizing an electron-beam lithography system (EBL), having a 5-nm titanium layer and a 25-nm gold layer. Hilbert-fractal design is used with different line widths up to 140 nm. An improvement of the emitted THz power by an approximate factor of two is observed using this nanostructure.
Dielectric metasurfaces in photoconductive terahertz devices can be used as an alternative method to enhance the photoconductive THz emitters’ performance instead of the plasmonic structure [42]. Although the plasmonic structure delivers better THz field improvement over the dielectric structure, the dielectric structure has a substantial characteristic which is the lack of dissipation [43]. In addition, the optical absorption of the incident light (laser) onto the photoconductive device can be improved by reducing the Fresnel losses, which can be done by using thin films of dielectric materials on top of the photoconductive gap. These dielectric materials (thin films) include SiO2, Si3N4, Al2O3, and TiO2 [44, 45]. Figure 5 shows a bowtie antenna having a layer of TiO2 being coated on the photoconductive gap, in (a) the schematic view of the photoconductive THz emitter, (b) the SEM image of the photoconductive THz emitter, and (c) the THz spectral amplitude obtained with using TiO2 layer (red) and without using TiO2 layer (black), “from [45]”.
The bowtie photoconductive antenna with TiO2 layer, coated on the photoconductive gap, in (a) the schematic view of the photoconductive THz emitter, (b) the SEM image of the photoconductive THz emitter, and (c) the THz spectral amplitude obtained with using TiO2 layer (red) and without using TiO2 layer (black). This figure is reprinted from [
The grating structure manifests itself as a periodic array of grooves, lines, slits, etc. The grating structure of the photoconductive devices for THz generation has been studied according to the effective medium approximations (or effective medium theory). The theory can be applied to describe the interaction of light with the grating structure (subwavelength) [46]. Chia et al. have modeled and simulated the influence of grating structure on the THz emission performance by COMSOL Multiphysics software with an insight into the effects of grating geometrical parameters. The author funds an improvement of about 1.63 of the photocurrents obtained by an optimized grating structure of photoconductive THz emitter over the planer emitter structure. This is due to the higher photon absorption, which leads to and leads to more carrier generation within photoconductive material, thus higher photocurrent is observed [46]. Figure 6 shows the simulated grating structure of LT-GaAs and its effects, as in a) the upper diagram shows the surface of planner photoconductive THz emitter, the lower diagram shows grating structure of the photoconductive THz emitter used in the simulation, and b) the normalized electronic concertation obtained by the two different simulated photoconductive THz emitters, “from [46]”.
The simulated grating structure of LT-GaAs, as in (a) the upper diagram shows the surface of planner photoconductive THz emitter, the lower diagram shows grating structure of the photoconductive THz emitter, and (b) the normalized electronic concertation obtained by the two different simulated photoconductive THz emitters. This figure is reprinted from [
Nowadays, the development of photoconductive devices regarding materials and structure is a hot research topic. Several publications have discussed many schemes to achieve higher performance of THz generation by photoconductive devices to facilitate the applications in cutting-edge technologies such as THz spectroscopy, THz sensing, and THz imaging. For photoconductive materials, the research focuses on the quantum dots as well as promotes material properties such as the carrier lifetime and carrier mobility. For the photoconductive structure, the implementation of plasmonic and nanostructures shows its advantage for the aforementioned applications. However, utilizing some novel ideas such as grating structure and a precise selection of the dielectric material is demonstrated to boost the performance of photoconductive devices further.
This chapter presented the photoconductive devices for THz emission. Several materials have been employed as photoconductive materials. However, GaAs is a typical material for these applications, particularly for the sapphire femtosecond pulsed laser sources, which emit at the same range of the bandgap energy of GaAs. Furthermore, several photoconductive structures have been employed. The plasmonic structure shows the highest impact of the photoconductive THz emitters’ performance over the microstructure photoconductive THz emitters. On top of that, the screening effects of the THz field amplitude is an issue limiting the linear scaling of the THz field with the pump fluence. Such limitations can be diminished using a large-aperture photoconductive antenna. At the end of this chapter, the improvement of these devices’ performance has been considered by viewing some recent work in this area. The work has also presented the influence of the quantum dots, the nanostructured electrodes (nonplasmonic) of the photoconductive device, the dielectric materials in photoconductive terahertz devices, and the grating structure on the photoconductive surface. It is hoped that the presented work can lay a role in continuing advancements of photoconductive devices.
The authors declare no conflict of interest.
Our books are published online and are accessible for free. However, if you are interested in ordering your hardcover copy, you can do so by contacting our Print Sales Department at orders@intechopen.com. All IntechOpen books are printed on demand in full-colour and delivered in signature packaging through free DHL Express delivery. A selection of our books in soft cover is also available through Amazon.
',metaTitle:"Order Print Copies",metaDescription:"Our books are published online and are accessible for free. However, if you are interested in ordering your printed copy, you can do so by contacting our Print Sales Department at orders@intechopen.com.\n\nOur hardcover books are carefully designed and printed on wood-free premium quality paper.\n\nThe paper size is 155 mm x 225 mm (6.1 X 8.8 inches).",metaKeywords:null,canonicalURL:"/page/order-print-copies",contentRaw:'[{"type":"htmlEditorComponent","content":"InTechOpen contributors can order print books at a special price ranging from:
\\n\\nFor a quote please contact us directly at orders@intechopen.com The quote will be sent to you within 1-2 business days.
\\n\\nAll of the books and chapters can be browsed online. To obtain InTechOpen's full book catalogue in PDF, please contact us.
\\n\\n\\n\\nIntechOpen works with award winning print-houses and we hold to the fact that all of our printed products are of the highest quality.
\\n\\nPrint copies of our publications are most often purchased as individual purchases by universities, libraries, institutions and academia personnel, hence increasing the visibility and outreach of our authors' published work among science communities and institutions. Our books are available at our direct Print Sales Department and through selected representatives throughout the world.
\\n\\nIndia - CBS Publishers & Distributors Pvt. Ltd.
\\n\\nASEAN - Books International
\\n\\nChina Publishers Services Ltd - CPS
\\n\\nMallory International Ltd
\\n\\nFor partnership opportunities, please contact orders@intechopen.com.
\\n\\n*The price does not include Value-Added Tax (VAT). Residents of European Union countries need to add a Book Value-Added Tax of 5%. Institutions and companies registered as VAT taxable entities in their own EU member state, will not pay VAT by providing us with their VAT registration number. This is made possible by the EU reverse charge method.
\\n"}]'},components:[{type:"htmlEditorComponent",content:'InTechOpen contributors can order print books at a special price ranging from:
\n\nFor a quote please contact us directly at orders@intechopen.com The quote will be sent to you within 1-2 business days.
\n\nAll of the books and chapters can be browsed online. To obtain InTechOpen's full book catalogue in PDF, please contact us.
\n\n\n\nIntechOpen works with award winning print-houses and we hold to the fact that all of our printed products are of the highest quality.
\n\nPrint copies of our publications are most often purchased as individual purchases by universities, libraries, institutions and academia personnel, hence increasing the visibility and outreach of our authors' published work among science communities and institutions. Our books are available at our direct Print Sales Department and through selected representatives throughout the world.
\n\nIndia - CBS Publishers & Distributors Pvt. Ltd.
\n\nASEAN - Books International
\n\nChina Publishers Services Ltd - CPS
\n\nMallory International Ltd
\n\nFor partnership opportunities, please contact orders@intechopen.com.
\n\n*The price does not include Value-Added Tax (VAT). Residents of European Union countries need to add a Book Value-Added Tax of 5%. Institutions and companies registered as VAT taxable entities in their own EU member state, will not pay VAT by providing us with their VAT registration number. This is made possible by the EU reverse charge method.
\n'}]},successStories:{items:[]},authorsAndEditors:{filterParams:{},profiles:[{id:"396",title:"Dr.",name:"Vedran",middleName:null,surname:"Kordic",slug:"vedran-kordic",fullName:"Vedran Kordic",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/396/images/7281_n.png",biography:"After obtaining his Master's degree in Mechanical Engineering he continued his education at the Vienna University of Technology where he obtained his PhD degree in 2004. He worked as a researcher at the Automation and Control Institute, Faculty of Electrical Engineering, Vienna University of Technology until 2008. His studies in robotics lead him not only to a PhD degree but also inspired him to co-found and build the International Journal of Advanced Robotic Systems - world's first Open Access journal in the field of robotics.",institutionString:null,institution:{name:"TU Wien",country:{name:"Austria"}}},{id:"441",title:"Ph.D.",name:"Jaekyu",middleName:null,surname:"Park",slug:"jaekyu-park",fullName:"Jaekyu Park",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/441/images/1881_n.jpg",biography:null,institutionString:null,institution:{name:"LG Corporation (South Korea)",country:{name:"Korea, South"}}},{id:"465",title:"Dr",name:"Christian",middleName:null,surname:"Martens",slug:"christian-martens",fullName:"Christian Martens",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"479",title:"Dr.",name:"Valentina",middleName:null,surname:"Colla",slug:"valentina-colla",fullName:"Valentina Colla",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/479/images/358_n.jpg",biography:null,institutionString:null,institution:{name:"Sant'Anna School of Advanced Studies",country:{name:"Italy"}}},{id:"494",title:"PhD",name:"Loris",middleName:null,surname:"Nanni",slug:"loris-nanni",fullName:"Loris Nanni",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/494/images/system/494.jpg",biography:"Loris Nanni received his Master Degree cum laude on June-2002 from the University of Bologna, and the April 26th 2006 he received his Ph.D. in Computer Engineering at DEIS, University of Bologna. On September, 29th 2006 he has won a post PhD fellowship from the university of Bologna (from October 2006 to October 2008), at the competitive examination he was ranked first in the industrial engineering area. He extensively served as referee for several international journals. He is author/coauthor of more than 100 research papers. He has been involved in some projects supported by MURST and European Community. His research interests include pattern recognition, bioinformatics, and biometric systems (fingerprint classification and recognition, signature verification, face recognition).",institutionString:null,institution:null},{id:"496",title:"Dr.",name:"Carlos",middleName:null,surname:"Leon",slug:"carlos-leon",fullName:"Carlos Leon",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Seville",country:{name:"Spain"}}},{id:"512",title:"Dr.",name:"Dayang",middleName:null,surname:"Jawawi",slug:"dayang-jawawi",fullName:"Dayang Jawawi",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Technology Malaysia",country:{name:"Malaysia"}}},{id:"528",title:"Dr.",name:"Kresimir",middleName:null,surname:"Delac",slug:"kresimir-delac",fullName:"Kresimir Delac",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/528/images/system/528.jpg",biography:"K. Delac received his B.Sc.E.E. degree in 2003 and is currentlypursuing a Ph.D. degree at the University of Zagreb, Faculty of Electrical Engineering andComputing. His current research interests are digital image analysis, pattern recognition andbiometrics.",institutionString:null,institution:{name:"University of Zagreb",country:{name:"Croatia"}}},{id:"557",title:"Dr.",name:"Andon",middleName:"Venelinov",surname:"Topalov",slug:"andon-topalov",fullName:"Andon Topalov",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/557/images/1927_n.jpg",biography:"Dr. Andon V. Topalov received the MSc degree in Control Engineering from the Faculty of Information Systems, Technologies, and Automation at Moscow State University of Civil Engineering (MGGU) in 1979. He then received his PhD degree in Control Engineering from the Department of Automation and Remote Control at Moscow State Mining University (MGSU), Moscow, in 1984. From 1985 to 1986, he was a Research Fellow in the Research Institute for Electronic Equipment, ZZU AD, Plovdiv, Bulgaria. In 1986, he joined the Department of Control Systems, Technical University of Sofia at the Plovdiv campus, where he is presently a Full Professor. He has held long-term visiting Professor/Scholar positions at various institutions in South Korea, Turkey, Mexico, Greece, Belgium, UK, and Germany. And he has coauthored one book and authored or coauthored more than 80 research papers in conference proceedings and journals. His current research interests are in the fields of intelligent control and robotics.",institutionString:null,institution:{name:"Technical University of Sofia",country:{name:"Bulgaria"}}},{id:"585",title:"Prof.",name:"Munir",middleName:null,surname:"Merdan",slug:"munir-merdan",fullName:"Munir Merdan",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/585/images/system/585.jpg",biography:"Munir Merdan received the M.Sc. degree in mechanical engineering from the Technical University of Sarajevo, Bosnia and Herzegovina, in 2001, and the Ph.D. degree in electrical engineering from the Vienna University of Technology, Vienna, Austria, in 2009.Since 2005, he has been at the Automation and Control Institute, Vienna University of Technology, where he is currently a Senior Researcher. His research interests include the application of agent technology for achieving agile control in the manufacturing environment.",institutionString:null,institution:null},{id:"605",title:"Prof",name:"Dil",middleName:null,surname:"Hussain",slug:"dil-hussain",fullName:"Dil Hussain",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/605/images/system/605.jpg",biography:"Dr. Dil Muhammad Akbar Hussain is a professor of Electronics Engineering & Computer Science at the Department of Energy Technology, Aalborg University Denmark. Professor Akbar has a Master degree in Digital Electronics from Govt. College University, Lahore Pakistan and a P-hD degree in Control Engineering from the School of Engineering and Applied Sciences, University of Sussex United Kingdom. Aalborg University has Two Satellite Campuses, one in Copenhagen (Aalborg University Copenhagen) and the other in Esbjerg (Aalborg University Esbjerg).\n· He is a member of prestigious IEEE (Institute of Electrical and Electronics Engineers), and IAENG (International Association of Engineers) organizations. \n· He is the chief Editor of the Journal of Software Engineering.\n· He is the member of the Editorial Board of International Journal of Computer Science and Software Technology (IJCSST) and International Journal of Computer Engineering and Information Technology. \n· He is also the Editor of Communication in Computer and Information Science CCIS-20 by Springer.\n· Reviewer For Many Conferences\nHe is the lead person in making collaboration agreements between Aalborg University and many universities of Pakistan, for which the MOU’s (Memorandum of Understanding) have been signed.\nProfessor Akbar is working in Academia since 1990, he started his career as a Lab demonstrator/TA at the University of Sussex. After finishing his P. hD degree in 1992, he served in the Industry as a Scientific Officer and continued his academic career as a visiting scholar for a number of educational institutions. In 1996 he joined National University of Science & Technology Pakistan (NUST) as an Associate Professor; NUST is one of the top few universities in Pakistan. In 1999 he joined an International Company Lineo Inc, Canada as Manager Compiler Group, where he headed the group for developing Compiler Tool Chain and Porting of Operating Systems for the BLACKfin processor. The processor development was a joint venture by Intel and Analog Devices. In 2002 Lineo Inc., was taken over by another company, so he joined Aalborg University Denmark as an Assistant Professor.\nProfessor Akbar has truly a multi-disciplined career and he continued his legacy and making progress in many areas of his interests both in teaching and research. He has contributed in stochastic estimation of control area especially, in the Multiple Target Tracking and Interactive Multiple Model (IMM) research, Ball & Beam Control Problem, Robotics, Levitation Control. He has contributed in developing Algorithms for Fingerprint Matching, Computer Vision and Face Recognition. He has been supervising Pattern Recognition, Formal Languages and Distributed Processing projects for several years. He has reviewed many books on Management, Computer Science. Currently, he is an active and permanent reviewer for many international conferences and symposia and the program committee member for many international conferences.\nIn teaching he has taught the core computer science subjects like, Digital Design, Real Time Embedded System Programming, Operating Systems, Software Engineering, Data Structures, Databases, Compiler Construction. In the Engineering side, Digital Signal Processing, Computer Architecture, Electronics Devices, Digital Filtering and Engineering Management.\nApart from his Academic Interest and activities he loves sport especially, Cricket, Football, Snooker and Squash. He plays cricket for Esbjerg city in the second division team as an opener wicket keeper batsman. He is a very good player of squash but has not played squash since his arrival in Denmark.",institutionString:null,institution:null},{id:"611",title:"Prof.",name:"T",middleName:null,surname:"Nagarajan",slug:"t-nagarajan",fullName:"T Nagarajan",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Universiti Teknologi Petronas",country:{name:"Malaysia"}}}],filtersByRegion:[{group:"region",caption:"North America",value:1,count:6675},{group:"region",caption:"Middle and South America",value:2,count:5955},{group:"region",caption:"Africa",value:3,count:2458},{group:"region",caption:"Asia",value:4,count:12717},{group:"region",caption:"Australia and Oceania",value:5,count:1017},{group:"region",caption:"Europe",value:6,count:17720}],offset:12,limit:12,total:134177},chapterEmbeded:{data:{}},editorApplication:{success:null,errors:{}},ofsBooks:{filterParams:{sort:"dateEndThirdStepPublish",topicId:"5"},books:[{type:"book",id:"11616",title:"Foraging",subtitle:null,isOpenForSubmission:!0,hash:"955b60bb658c8d1a09dd4efc9bf6674b",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/11616.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11794",title:"Coconut Cultivation",subtitle:null,isOpenForSubmission:!0,hash:"48e1cb42a4162f64cae3a2e777472f21",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/11794.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11809",title:"Lagomorpha",subtitle:null,isOpenForSubmission:!0,hash:"1e8fd5779205c16e5797b05455dc5be0",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/11809.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11610",title:"New Insights in Herbicide Science",subtitle:null,isOpenForSubmission:!0,hash:"eb3830b8176caf3d1fd52c32313c5168",slug:null,bookSignature:"Ph.D. Kassio Ferreira Mendes",coverURL:"https://cdn.intechopen.com/books/images_new/11610.jpg",editedByType:null,editors:[{id:"197720",title:"Ph.D.",name:"Kassio",surname:"Ferreira Mendes",slug:"kassio-ferreira-mendes",fullName:"Kassio Ferreira Mendes"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"12142",title:"Prunus",subtitle:null,isOpenForSubmission:!0,hash:"30b850eaa9714914bf001664c9b324be",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/12142.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"12146",title:"Cellulose",subtitle:null,isOpenForSubmission:!0,hash:"b1196cf20a9e42db795c2d647681aa9d",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/12146.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"12147",title:"Abiotic Stress in Plants",subtitle:null,isOpenForSubmission:!0,hash:"f3d8c31029650b7ce536da7ab9d7a5a0",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/12147.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"12148",title:"Cucurbitaceae",subtitle:null,isOpenForSubmission:!0,hash:"0029e5c84528142bf2eff0cbd5b14fa2",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/12148.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"12149",title:"Solanum tuberosum",subtitle:null,isOpenForSubmission:!0,hash:"39bdc8ce8b54bc666a3ab765a29c6edd",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/12149.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"12151",title:"Poultry Farming",subtitle:null,isOpenForSubmission:!0,hash:"acd89c676ce6c3da7af23d64e30828f6",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/12151.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"12154",title:"Organic Fertilizers",subtitle:null,isOpenForSubmission:!0,hash:"8634d6ecdb6fc207336d8b95a169e400",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/12154.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"12156",title:"Legumes",subtitle:null,isOpenForSubmission:!0,hash:"a97becd6aa14a480ce28c05a3116f639",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/12156.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],filtersByTopic:[{group:"topic",caption:"Agricultural and Biological Sciences",value:5,count:38},{group:"topic",caption:"Biochemistry, Genetics and Molecular Biology",value:6,count:13},{group:"topic",caption:"Business, Management and Economics",value:7,count:7},{group:"topic",caption:"Chemistry",value:8,count:23},{group:"topic",caption:"Computer and Information Science",value:9,count:24},{group:"topic",caption:"Earth and Planetary Sciences",value:10,count:15},{group:"topic",caption:"Engineering",value:11,count:65},{group:"topic",caption:"Environmental Sciences",value:12,count:10},{group:"topic",caption:"Immunology and Microbiology",value:13,count:16},{group:"topic",caption:"Materials Science",value:14,count:25},{group:"topic",caption:"Mathematics",value:15,count:11},{group:"topic",caption:"Medicine",value:16,count:116},{group:"topic",caption:"Nanotechnology and Nanomaterials",value:17,count:6},{group:"topic",caption:"Neuroscience",value:18,count:4},{group:"topic",caption:"Pharmacology, Toxicology and Pharmaceutical Science",value:19,count:9},{group:"topic",caption:"Physics",value:20,count:9},{group:"topic",caption:"Psychology",value:21,count:10},{group:"topic",caption:"Robotics",value:22,count:2},{group:"topic",caption:"Social Sciences",value:23,count:9},{group:"topic",caption:"Veterinary Medicine and Science",value:25,count:4}],offset:12,limit:12,total:68},popularBooks:{featuredBooks:[{type:"book",id:"10858",title:"MOOC (Massive Open Online Courses)",subtitle:null,isOpenForSubmission:!1,hash:"d32f86793bc72dde32532f509b1ec5b0",slug:"mooc-massive-open-online-courses-",bookSignature:"Dragan Cvetković",coverURL:"https://cdn.intechopen.com/books/images_new/10858.jpg",editors:[{id:"101330",title:"Dr.",name:"Dragan",middleName:"Mladen",surname:"Cvetković",slug:"dragan-cvetkovic",fullName:"Dragan Cvetković"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10195",title:"Serotonin and the CNS",subtitle:"New Developments in Pharmacology and Therapeutics",isOpenForSubmission:!1,hash:"7ed9d96da98233a885bd2869a8056c36",slug:"serotonin-and-the-cns-new-developments-in-pharmacology-and-therapeutics",bookSignature:"Berend Olivier",coverURL:"https://cdn.intechopen.com/books/images_new/10195.jpg",editors:[{id:"71579",title:"Prof.",name:"Berend",middleName:null,surname:"Olivier",slug:"berend-olivier",fullName:"Berend Olivier"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10755",title:"Corporate Governance",subtitle:"Recent Advances and Perspectives",isOpenForSubmission:!1,hash:"ffe06d1d5c4bf0fc2e63511825fe1257",slug:"corporate-governance-recent-advances-and-perspectives",bookSignature:"Okechukwu Lawrence Emeagwali and Feyza Bhatti",coverURL:"https://cdn.intechopen.com/books/images_new/10755.jpg",editors:[{id:"196317",title:"Associate Prof.",name:"Okechukwu Lawrence",middleName:null,surname:"Emeagwali",slug:"okechukwu-lawrence-emeagwali",fullName:"Okechukwu Lawrence Emeagwali"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11120",title:"Environmental Impact and Remediation of Heavy Metals",subtitle:null,isOpenForSubmission:!1,hash:"9e77514288e7394f1e6cd13481af3509",slug:"environmental-impact-and-remediation-of-heavy-metals",bookSignature:"Hosam M. Saleh and Amal I. Hassan",coverURL:"https://cdn.intechopen.com/books/images_new/11120.jpg",editors:[{id:"144691",title:"Prof.",name:"Hosam M.",middleName:null,surname:"Saleh",slug:"hosam-m.-saleh",fullName:"Hosam M. Saleh"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10901",title:"Grapes and Wine",subtitle:null,isOpenForSubmission:!1,hash:"5d7f2aa74874444bc6986e613ccebd7c",slug:"grapes-and-wine",bookSignature:"Antonio Morata, Iris Loira and Carmen González",coverURL:"https://cdn.intechopen.com/books/images_new/10901.jpg",editors:[{id:"180952",title:"Prof.",name:"Antonio",middleName:null,surname:"Morata",slug:"antonio-morata",fullName:"Antonio Morata"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11080",title:"Engineering Principles",subtitle:"Welding and Residual Stresses",isOpenForSubmission:!1,hash:"6c07a13a113bce94174b40096f30fb5e",slug:"engineering-principles-welding-and-residual-stresses",bookSignature:"Kavian Omar Cooke and Ronaldo Câmara Cozza",coverURL:"https://cdn.intechopen.com/books/images_new/11080.jpg",editors:[{id:"138778",title:"Dr.",name:"Kavian",middleName:"Omar",surname:"Cooke",slug:"kavian-cooke",fullName:"Kavian Cooke"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11332",title:"Essential Oils",subtitle:"Advances in Extractions and Biological Applications",isOpenForSubmission:!1,hash:"742e6cae3a35686f975edc8d7f9afa94",slug:"essential-oils-advances-in-extractions-and-biological-applications",bookSignature:"Mozaniel Santana de Oliveira and Eloisa Helena de Aguiar Andrade",coverURL:"https://cdn.intechopen.com/books/images_new/11332.jpg",editors:[{id:"195290",title:"Ph.D.",name:"Mozaniel",middleName:null,surname:"Santana De Oliveira",slug:"mozaniel-santana-de-oliveira",fullName:"Mozaniel Santana De Oliveira"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11029",title:"Hepatitis B",subtitle:null,isOpenForSubmission:!1,hash:"609701f502efc3538c112ff47a2c2119",slug:"hepatitis-b",bookSignature:"Luis Rodrigo",coverURL:"https://cdn.intechopen.com/books/images_new/11029.jpg",editors:[{id:"73208",title:"Prof.",name:"Luis",middleName:null,surname:"Rodrigo",slug:"luis-rodrigo",fullName:"Luis Rodrigo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9537",title:"Human Rights in the Contemporary World",subtitle:null,isOpenForSubmission:!1,hash:"54f05b93812fd434f3962956d6413a6b",slug:"human-rights-in-the-contemporary-world",bookSignature:"Trudy Corrigan",coverURL:"https://cdn.intechopen.com/books/images_new/9537.jpg",editors:[{id:"197557",title:"Dr.",name:"Trudy",middleName:null,surname:"Corrigan",slug:"trudy-corrigan",fullName:"Trudy Corrigan"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11371",title:"Cerebral Circulation",subtitle:"Updates on Models, Diagnostics and Treatments of Related Diseases",isOpenForSubmission:!1,hash:"e2d3335445d2852d0b906bb9750e939f",slug:"cerebral-circulation-updates-on-models-diagnostics-and-treatments-of-related-diseases",bookSignature:"Alba Scerrati, Luca Ricciardi and Flavia Dones",coverURL:"https://cdn.intechopen.com/books/images_new/11371.jpg",editors:[{id:"182614",title:"Dr.",name:"Alba",middleName:null,surname:"Scerrati",slug:"alba-scerrati",fullName:"Alba Scerrati"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11012",title:"Radiopharmaceuticals",subtitle:"Current Research for Better Diagnosis and Therapy",isOpenForSubmission:!1,hash:"f9046d6f96148b285e776f384991120d",slug:"radiopharmaceuticals-current-research-for-better-diagnosis-and-therapy",bookSignature:"Farid A. Badria",coverURL:"https://cdn.intechopen.com/books/images_new/11012.jpg",editors:[{id:"41865",title:"Prof.",name:"Farid A.",middleName:null,surname:"Badria",slug:"farid-a.-badria",fullName:"Farid A. Badria"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9974",title:"E-Learning and Digital Education in the Twenty-First Century",subtitle:null,isOpenForSubmission:!1,hash:"88b58d66e975df20425fc1dfd22d53aa",slug:"e-learning-and-digital-education-in-the-twenty-first-century",bookSignature:"M. Mahruf C. Shohel",coverURL:"https://cdn.intechopen.com/books/images_new/9974.jpg",editors:[{id:"94099",title:"Dr.",name:"M. Mahruf C.",middleName:null,surname:"Shohel",slug:"m.-mahruf-c.-shohel",fullName:"M. Mahruf C. Shohel"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],offset:12,limit:12,total:4431},hotBookTopics:{hotBooks:[],offset:0,limit:12,total:null},publish:{},publishingProposal:{success:null,errors:{}},books:{featuredBooks:[{type:"book",id:"10858",title:"MOOC (Massive Open Online Courses)",subtitle:null,isOpenForSubmission:!1,hash:"d32f86793bc72dde32532f509b1ec5b0",slug:"mooc-massive-open-online-courses-",bookSignature:"Dragan Cvetković",coverURL:"https://cdn.intechopen.com/books/images_new/10858.jpg",publishedDate:"June 23rd 2022",numberOfDownloads:1677,editors:[{id:"101330",title:"Dr.",name:"Dragan",middleName:"Mladen",surname:"Cvetković",slug:"dragan-cvetkovic",fullName:"Dragan Cvetković"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10195",title:"Serotonin and the CNS",subtitle:"New Developments in Pharmacology and Therapeutics",isOpenForSubmission:!1,hash:"7ed9d96da98233a885bd2869a8056c36",slug:"serotonin-and-the-cns-new-developments-in-pharmacology-and-therapeutics",bookSignature:"Berend Olivier",coverURL:"https://cdn.intechopen.com/books/images_new/10195.jpg",publishedDate:"June 23rd 2022",numberOfDownloads:1337,editors:[{id:"71579",title:"Prof.",name:"Berend",middleName:null,surname:"Olivier",slug:"berend-olivier",fullName:"Berend Olivier"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10755",title:"Corporate Governance",subtitle:"Recent Advances and Perspectives",isOpenForSubmission:!1,hash:"ffe06d1d5c4bf0fc2e63511825fe1257",slug:"corporate-governance-recent-advances-and-perspectives",bookSignature:"Okechukwu Lawrence Emeagwali and Feyza Bhatti",coverURL:"https://cdn.intechopen.com/books/images_new/10755.jpg",publishedDate:"June 23rd 2022",numberOfDownloads:1309,editors:[{id:"196317",title:"Associate Prof.",name:"Okechukwu Lawrence",middleName:null,surname:"Emeagwali",slug:"okechukwu-lawrence-emeagwali",fullName:"Okechukwu Lawrence Emeagwali"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11120",title:"Environmental Impact and Remediation of Heavy Metals",subtitle:null,isOpenForSubmission:!1,hash:"9e77514288e7394f1e6cd13481af3509",slug:"environmental-impact-and-remediation-of-heavy-metals",bookSignature:"Hosam M. Saleh and Amal I. Hassan",coverURL:"https://cdn.intechopen.com/books/images_new/11120.jpg",publishedDate:"June 23rd 2022",numberOfDownloads:847,editors:[{id:"144691",title:"Prof.",name:"Hosam M.",middleName:null,surname:"Saleh",slug:"hosam-m.-saleh",fullName:"Hosam M. Saleh"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10901",title:"Grapes and Wine",subtitle:null,isOpenForSubmission:!1,hash:"5d7f2aa74874444bc6986e613ccebd7c",slug:"grapes-and-wine",bookSignature:"Antonio Morata, Iris Loira and Carmen González",coverURL:"https://cdn.intechopen.com/books/images_new/10901.jpg",publishedDate:"June 15th 2022",numberOfDownloads:2273,editors:[{id:"180952",title:"Prof.",name:"Antonio",middleName:null,surname:"Morata",slug:"antonio-morata",fullName:"Antonio Morata"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11080",title:"Engineering Principles",subtitle:"Welding and Residual Stresses",isOpenForSubmission:!1,hash:"6c07a13a113bce94174b40096f30fb5e",slug:"engineering-principles-welding-and-residual-stresses",bookSignature:"Kavian Omar Cooke and Ronaldo Câmara Cozza",coverURL:"https://cdn.intechopen.com/books/images_new/11080.jpg",publishedDate:"June 23rd 2022",numberOfDownloads:591,editors:[{id:"138778",title:"Dr.",name:"Kavian",middleName:"Omar",surname:"Cooke",slug:"kavian-cooke",fullName:"Kavian Cooke"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11332",title:"Essential Oils",subtitle:"Advances in Extractions and Biological Applications",isOpenForSubmission:!1,hash:"742e6cae3a35686f975edc8d7f9afa94",slug:"essential-oils-advances-in-extractions-and-biological-applications",bookSignature:"Mozaniel Santana de Oliveira and Eloisa Helena de Aguiar Andrade",coverURL:"https://cdn.intechopen.com/books/images_new/11332.jpg",publishedDate:"June 23rd 2022",numberOfDownloads:515,editors:[{id:"195290",title:"Ph.D.",name:"Mozaniel",middleName:null,surname:"Santana De Oliveira",slug:"mozaniel-santana-de-oliveira",fullName:"Mozaniel Santana De Oliveira"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11029",title:"Hepatitis B",subtitle:null,isOpenForSubmission:!1,hash:"609701f502efc3538c112ff47a2c2119",slug:"hepatitis-b",bookSignature:"Luis Rodrigo",coverURL:"https://cdn.intechopen.com/books/images_new/11029.jpg",publishedDate:"June 23rd 2022",numberOfDownloads:413,editors:[{id:"73208",title:"Prof.",name:"Luis",middleName:null,surname:"Rodrigo",slug:"luis-rodrigo",fullName:"Luis Rodrigo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9537",title:"Human Rights in the Contemporary World",subtitle:null,isOpenForSubmission:!1,hash:"54f05b93812fd434f3962956d6413a6b",slug:"human-rights-in-the-contemporary-world",bookSignature:"Trudy Corrigan",coverURL:"https://cdn.intechopen.com/books/images_new/9537.jpg",publishedDate:"June 8th 2022",numberOfDownloads:2194,editors:[{id:"197557",title:"Dr.",name:"Trudy",middleName:null,surname:"Corrigan",slug:"trudy-corrigan",fullName:"Trudy Corrigan"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11371",title:"Cerebral Circulation",subtitle:"Updates on Models, Diagnostics and Treatments of Related Diseases",isOpenForSubmission:!1,hash:"e2d3335445d2852d0b906bb9750e939f",slug:"cerebral-circulation-updates-on-models-diagnostics-and-treatments-of-related-diseases",bookSignature:"Alba Scerrati, Luca Ricciardi and Flavia Dones",coverURL:"https://cdn.intechopen.com/books/images_new/11371.jpg",publishedDate:"June 23rd 2022",numberOfDownloads:341,editors:[{id:"182614",title:"Dr.",name:"Alba",middleName:null,surname:"Scerrati",slug:"alba-scerrati",fullName:"Alba Scerrati"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],latestBooks:[{type:"book",id:"11043",title:"Endometriosis",subtitle:"Recent Advances, New Perspectives and Treatments",isOpenForSubmission:!1,hash:"7baf1c70b11d41400bb9302ae9411ca4",slug:"endometriosis-recent-advances-new-perspectives-and-treatments",bookSignature:"Giovana Ap. Gonçalves",coverURL:"https://cdn.intechopen.com/books/images_new/11043.jpg",editedByType:"Edited by",publishedDate:"June 28th 2022",editors:[{id:"185930",title:"Associate Prof.",name:"Giovana",middleName:null,surname:"Gonçalves",slug:"giovana-goncalves",fullName:"Giovana Gonçalves"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10536",title:"Campylobacter",subtitle:null,isOpenForSubmission:!1,hash:"c4b132b741dd0a2ed539b824ab63965f",slug:"campylobacter",bookSignature:"Guillermo Tellez-Isaias and Saeed El-Ashram",coverURL:"https://cdn.intechopen.com/books/images_new/10536.jpg",editedByType:"Edited by",publishedDate:"June 28th 2022",editors:[{id:"73465",title:"Dr.",name:"Guillermo",middleName:null,surname:"Téllez",slug:"guillermo-tellez",fullName:"Guillermo Téllez"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10798",title:"Starch",subtitle:"Evolution and Recent Advances",isOpenForSubmission:!1,hash:"f197f6062c1574a9a90e50a369271bcf",slug:"starch-evolution-and-recent-advances",bookSignature:"Martins Ochubiojo Emeje",coverURL:"https://cdn.intechopen.com/books/images_new/10798.jpg",editedByType:"Edited by",publishedDate:"June 28th 2022",editors:[{id:"94311",title:"Prof.",name:"Martins",middleName:"Ochubiojo",surname:"Ochubiojo Emeje",slug:"martins-ochubiojo-emeje",fullName:"Martins Ochubiojo Emeje"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11083",title:"Hazardous Waste Management",subtitle:null,isOpenForSubmission:!1,hash:"d553bd4f6f1c4b115ca69bd19faac7dc",slug:"hazardous-waste-management",bookSignature:"Rajesh Banu Jeyakumar, Kavitha Sankarapandian and Yukesh Kannah Ravi",coverURL:"https://cdn.intechopen.com/books/images_new/11083.jpg",editedByType:"Edited by",publishedDate:"June 28th 2022",editors:[{id:"218539",title:"Dr.",name:"Rajesh Banu",middleName:null,surname:"Jeyakumar",slug:"rajesh-banu-jeyakumar",fullName:"Rajesh Banu Jeyakumar"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10848",title:"Tribology of Machine Elements",subtitle:"Fundamentals and Applications",isOpenForSubmission:!1,hash:"3c4ca4c4692ca8d4fa749b4ae81ec1fa",slug:"tribology-of-machine-elements-fundamentals-and-applications",bookSignature:"Giuseppe Pintaude, Tiago Cousseau and Anna Rudawska",coverURL:"https://cdn.intechopen.com/books/images_new/10848.jpg",editedByType:"Edited by",publishedDate:"June 28th 2022",editors:[{id:"18347",title:"Prof.",name:"Giuseppe",middleName:null,surname:"Pintaude",slug:"giuseppe-pintaude",fullName:"Giuseppe Pintaude"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10856",title:"Crude Oil",subtitle:"New Technologies and Recent Approaches",isOpenForSubmission:!1,hash:"8d0a7ca35b3de95b295dc4eab39a087e",slug:"crude-oil-new-technologies-and-recent-approaches",bookSignature:"Manar Elsayed Abdel-Raouf and Mohamed Hasan El-Keshawy",coverURL:"https://cdn.intechopen.com/books/images_new/10856.jpg",editedByType:"Edited by",publishedDate:"June 28th 2022",editors:[{id:"102626",title:"Prof.",name:"Manar",middleName:null,surname:"Elsayed Abdel-Raouf",slug:"manar-elsayed-abdel-raouf",fullName:"Manar Elsayed Abdel-Raouf"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9625",title:"Spinocerebellar Ataxia",subtitle:"Concepts, Particularities and Generalities",isOpenForSubmission:!1,hash:"365a7025fd46eb45de2549bdd9d50b98",slug:"spinocerebellar-ataxia-concepts-particularities-and-generalities",bookSignature:"Patricia Bozzetto Ambrosi",coverURL:"https://cdn.intechopen.com/books/images_new/9625.jpg",editedByType:"Edited by",publishedDate:"June 28th 2022",editors:[{id:"221787",title:"Dr.",name:"Patricia",middleName:null,surname:"Bozzetto Ambrosi",slug:"patricia-bozzetto-ambrosi",fullName:"Patricia Bozzetto Ambrosi"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10905",title:"Plant Defense Mechanisms",subtitle:null,isOpenForSubmission:!1,hash:"84ad5b27dde5f01dc76087d0fd6fa834",slug:"plant-defense-mechanisms",bookSignature:"Josphert Ngui Kimatu",coverURL:"https://cdn.intechopen.com/books/images_new/10905.jpg",editedByType:"Edited by",publishedDate:"June 28th 2022",editors:[{id:"224171",title:"Prof.",name:"Josphert N.",middleName:null,surname:"Kimatu",slug:"josphert-n.-kimatu",fullName:"Josphert N. Kimatu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10686",title:"Natural Gas",subtitle:"New Perspectives and Future Developments",isOpenForSubmission:!1,hash:"581763788a6a59e653a9d1d9b5a42d79",slug:"natural-gas-new-perspectives-and-future-developments",bookSignature:"Maryam Takht Ravanchi",coverURL:"https://cdn.intechopen.com/books/images_new/10686.jpg",editedByType:"Edited by",publishedDate:"June 28th 2022",editors:[{id:"2416",title:"Dr.",name:"Maryam",middleName:null,surname:"Takht Ravanchi",slug:"maryam-takht-ravanchi",fullName:"Maryam Takht Ravanchi"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10988",title:"Railway Transport Planning and Manageme",subtitle:null,isOpenForSubmission:!1,hash:"5cb54cc53caedad9ec78372563c82e2c",slug:"railway-transport-planning-and-management",bookSignature:"Stefano de Luca, Roberta Di Pace and Chiara Fiori",coverURL:"https://cdn.intechopen.com/books/images_new/10988.jpg",editedByType:"Edited by",publishedDate:"June 28th 2022",editors:[{id:"271061",title:"Prof.",name:"Stefano",middleName:null,surname:"de Luca",slug:"stefano-de-luca",fullName:"Stefano de Luca"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},subject:{topic:{id:"203",title:"Telemedicine",slug:"telemedicine",parent:{id:"16",title:"Medicine",slug:"medicine"},numberOfBooks:7,numberOfSeries:0,numberOfAuthorsAndEditors:218,numberOfWosCitations:127,numberOfCrossrefCitations:135,numberOfDimensionsCitations:253,videoUrl:null,fallbackUrl:null,description:null},booksByTopicFilter:{topicId:"203",sort:"-publishedDate",limit:12,offset:0},booksByTopicCollection:[{type:"book",id:"10298",title:"Smart and Pervasive Healthcare",subtitle:null,isOpenForSubmission:!1,hash:"ddc0dea7e5b98335c187688d9c0c5b42",slug:"smart-and-pervasive-healthcare",bookSignature:"Urvashi Sharma",coverURL:"https://cdn.intechopen.com/books/images_new/10298.jpg",editedByType:"Edited by",editors:[{id:"105398",title:"Dr.",name:"Urvashi",middleName:null,surname:"Sharma",slug:"urvashi-sharma",fullName:"Urvashi Sharma"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8332",title:"Telehealth",subtitle:null,isOpenForSubmission:!1,hash:"dd9601c901f7fe3803ae69dbd571feba",slug:"telehealth",bookSignature:"Thomas F. Heston",coverURL:"https://cdn.intechopen.com/books/images_new/8332.jpg",editedByType:"Edited by",editors:[{id:"217926",title:"Dr.",name:"Thomas F.",middleName:null,surname:"Heston",slug:"thomas-f.-heston",fullName:"Thomas F. Heston"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3269",title:"Telemedicine",subtitle:null,isOpenForSubmission:!1,hash:"16571516432b37129c1a7ef56c4cf3aa",slug:"telemedicine",bookSignature:"Ramesh Madhavan and Shahram Khalid",coverURL:"https://cdn.intechopen.com/books/images_new/3269.jpg",editedByType:"Edited by",editors:[{id:"158803",title:"Dr.",name:"Ramesh",middleName:null,surname:"Madhavan",slug:"ramesh-madhavan",fullName:"Ramesh Madhavan"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"2824",title:"eHealth and Remote Monitoring",subtitle:null,isOpenForSubmission:!1,hash:"fee1441d7fee8b6585fb3b4e43452da0",slug:"ehealth-and-remote-monitoring",bookSignature:"Amir Hajjam El Hassani",coverURL:"https://cdn.intechopen.com/books/images_new/2824.jpg",editedByType:"Edited by",editors:[{id:"17524",title:"Dr.",name:"Amir",middleName:null,surname:"Hajjam El Hassani",slug:"amir-hajjam-el-hassani",fullName:"Amir Hajjam El Hassani"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"199",title:"Telemedicine",subtitle:"Techniques and Applications",isOpenForSubmission:!1,hash:"0f4c17e1a24003fb78612525315af711",slug:"telemedicine-techniques-and-applications",bookSignature:"Georgi Graschew and Stefan Rakowsky",coverURL:"https://cdn.intechopen.com/books/images_new/199.jpg",editedByType:"Edited by",editors:[{id:"11262",title:"Dr.",name:"Georgi",middleName:null,surname:"Graschew",slug:"georgi-graschew",fullName:"Georgi Graschew"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1403",title:"Advances in Telemedicine",subtitle:"Applications in Various Medical Disciplines and Geographical Regions",isOpenForSubmission:!1,hash:"a8e4b1e59964db023e14fe11b26a232d",slug:"advances-in-telemedicine-applications-in-various-medical-disciplines-and-geographical-regions",bookSignature:"Georgi Graschew and Theo A. Roelofs",coverURL:"https://cdn.intechopen.com/books/images_new/1403.jpg",editedByType:"Edited by",editors:[{id:"11262",title:"Dr.",name:"Georgi",middleName:null,surname:"Graschew",slug:"georgi-graschew",fullName:"Georgi Graschew"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"43",title:"Advances in Telemedicine",subtitle:"Technologies, Enabling Factors and Scenarios",isOpenForSubmission:!1,hash:"45f56e0955035bdce490c5383a06792f",slug:"advances-in-telemedicine-technologies-enabling-factors-and-scenarios",bookSignature:"Georgi Graschew and Theo A. Roelofs",coverURL:"https://cdn.intechopen.com/books/images_new/43.jpg",editedByType:"Edited by",editors:[{id:"11262",title:"Dr.",name:"Georgi",middleName:null,surname:"Graschew",slug:"georgi-graschew",fullName:"Georgi Graschew"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],booksByTopicTotal:7,seriesByTopicCollection:[],seriesByTopicTotal:0,mostCitedChapters:[{id:"64650",doi:"10.5772/intechopen.81723",title:"Barriers to Development of Telemedicine in Developing Countries",slug:"barriers-to-development-of-telemedicine-in-developing-countries",totalDownloads:2237,totalCrossrefCites:16,totalDimensionsCites:33,abstract:"Affordability, accessibility, availability, and quality of healthcare services have always been a burning issue for the mankind. The issue of health care is always crucial for the governments and countries irrespective of their financial status. Continuous efforts are being made by policy makers, administrators, and researchers to provide quality health care to the people at the cost that they can afford. Developed countries have adopted many alternative tools and technologies to leverage the supply of good health care but quality and cost of health care are still big issues in these countries. Developing countries are far behind in adopting technology to reduce the cost and improve the quality of health care. Telemedicine has emerged as a new hope to remove the bottlenecks in the healthcare seeking. Developing countries have adopted telemedicine technology in a hurry without proper planning and strategy. Despite more than two decades of adapting telemedicine, developing countries have not achieved any significant success in reducing the cost of care or improving the access of care. This chapter has tried to explore the various barriers to the development of telemedicine in developing countries. Proper enlisting and detailing of these barriers will definitely help governments to understand the loopholes and bottlenecks in the implementation of telemedicine and help them to develop appropriate solution.",book:{id:"8332",slug:"telehealth",title:"Telehealth",fullTitle:"Telehealth"},signatures:"Surya Bali",authors:null},{id:"14328",doi:"10.5772/14352",title:"Telemedicine in Dentistry (Teledentistry)",slug:"telemedicine-in-dentistry-teledentistry-",totalDownloads:5765,totalCrossrefCites:11,totalDimensionsCites:21,abstract:null,book:{id:"1403",slug:"advances-in-telemedicine-applications-in-various-medical-disciplines-and-geographical-regions",title:"Advances in Telemedicine",fullTitle:"Advances in Telemedicine: Applications in Various Medical Disciplines and Geographical Regions"},signatures:"Branko Mihailovic, Milan Miladinovic and Biljana Vujicic",authors:[{id:"17551",title:"Dr.",name:"Milan",middleName:null,surname:"Miladinovic",slug:"milan-miladinovic",fullName:"Milan Miladinovic"},{id:"17555",title:"Dr.",name:"Branko",middleName:null,surname:"Mihailovic",slug:"branko-mihailovic",fullName:"Branko Mihailovic"},{id:"17556",title:"Dr.",name:"Biljana",middleName:null,surname:"Vujicic",slug:"biljana-vujicic",fullName:"Biljana Vujicic"}]},{id:"16882",doi:"10.5772/16362",title:"A 2.4GHz Non-Contact Biosensor System for Continuous Monitoring of Vital-Signs",slug:"a-2-4ghz-non-contact-biosensor-system-for-continuous-monitoring-of-vital-signs",totalDownloads:4370,totalCrossrefCites:12,totalDimensionsCites:16,abstract:null,book:{id:"199",slug:"telemedicine-techniques-and-applications",title:"Telemedicine",fullTitle:"Telemedicine Techniques and Applications"},signatures:"Donald Lie, Ravi Ichapurapu, Suyash Jain, Jerry Lopez, Ronald Banister, Tam Nguyen and John Griswold",authors:[{id:"24852",title:"Prof.",name:"Donald",middleName:null,surname:"Lie",slug:"donald-lie",fullName:"Donald Lie"},{id:"119104",title:"Dr.",name:"Ravi",middleName:null,surname:"Ichapurapu",slug:"ravi-ichapurapu",fullName:"Ravi Ichapurapu"},{id:"119105",title:"Dr.",name:"Suyash",middleName:null,surname:"Jain",slug:"suyash-jain",fullName:"Suyash Jain"},{id:"119106",title:"Dr.",name:"Jerry",middleName:null,surname:"Lopez",slug:"jerry-lopez",fullName:"Jerry Lopez"},{id:"119107",title:"Dr.",name:"Ronald",middleName:null,surname:"Banister",slug:"ronald-banister",fullName:"Ronald Banister"},{id:"119108",title:"Dr.",name:"Tam",middleName:null,surname:"Nguyen",slug:"tam-nguyen",fullName:"Tam Nguyen"},{id:"119109",title:"Dr.",name:"John",middleName:null,surname:"Griswold",slug:"john-griswold",fullName:"John Griswold"}]},{id:"16881",doi:"10.5772/25399",title:"Clinical Decision Support Systems",slug:"clinical-decision-support-systems",totalDownloads:10196,totalCrossrefCites:8,totalDimensionsCites:13,abstract:null,book:{id:"199",slug:"telemedicine-techniques-and-applications",title:"Telemedicine",fullTitle:"Telemedicine Techniques and Applications"},signatures:"Dejan Dinevski, Uroš Bele, Tomislav Šarenac, Uroš Rajkovič and Olga Šušteršic",authors:[{id:"15129",title:"Prof.",name:"Dejan",middleName:null,surname:"Dinevski",slug:"dejan-dinevski",fullName:"Dejan Dinevski"},{id:"63337",title:"Dr.",name:"Uroš",middleName:null,surname:"Bele",slug:"uros-bele",fullName:"Uroš Bele"},{id:"63338",title:"MSc",name:"Tomislav",middleName:null,surname:"Sarenac",slug:"tomislav-sarenac",fullName:"Tomislav Sarenac"},{id:"63339",title:"Dr.",name:"Uroš",middleName:null,surname:"Rajkovi?",slug:"uros-rajkovi",fullName:"Uroš Rajkovi?"},{id:"63340",title:"Dr.",name:"Olga",middleName:null,surname:"Šušterši?",slug:"olga-sustersi",fullName:"Olga Šušterši?"}]},{id:"45211",doi:"10.5772/56116",title:"The Telemedicine Service Maturity Model: A Framework for the Measurement and Improvement of Telemedicine Services",slug:"the-telemedicine-service-maturity-model-a-framework-for-the-measurement-and-improvement-of-telemedic",totalDownloads:2961,totalCrossrefCites:4,totalDimensionsCites:12,abstract:null,book:{id:"3269",slug:"telemedicine",title:"Telemedicine",fullTitle:"Telemedicine"},signatures:"Liezl van Dyk and Cornelius S.L. Schutte",authors:[{id:"27481",title:"Ms",name:"Liezl",middleName:null,surname:"Van Dyk",slug:"liezl-van-dyk",fullName:"Liezl Van Dyk"},{id:"166270",title:"Prof.",name:"Corne",middleName:null,surname:"Schutte",slug:"corne-schutte",fullName:"Corne Schutte"}]}],mostDownloadedChaptersLast30Days:[{id:"64650",title:"Barriers to Development of Telemedicine in Developing Countries",slug:"barriers-to-development-of-telemedicine-in-developing-countries",totalDownloads:2237,totalCrossrefCites:16,totalDimensionsCites:33,abstract:"Affordability, accessibility, availability, and quality of healthcare services have always been a burning issue for the mankind. The issue of health care is always crucial for the governments and countries irrespective of their financial status. Continuous efforts are being made by policy makers, administrators, and researchers to provide quality health care to the people at the cost that they can afford. Developed countries have adopted many alternative tools and technologies to leverage the supply of good health care but quality and cost of health care are still big issues in these countries. Developing countries are far behind in adopting technology to reduce the cost and improve the quality of health care. Telemedicine has emerged as a new hope to remove the bottlenecks in the healthcare seeking. Developing countries have adopted telemedicine technology in a hurry without proper planning and strategy. Despite more than two decades of adapting telemedicine, developing countries have not achieved any significant success in reducing the cost of care or improving the access of care. This chapter has tried to explore the various barriers to the development of telemedicine in developing countries. Proper enlisting and detailing of these barriers will definitely help governments to understand the loopholes and bottlenecks in the implementation of telemedicine and help them to develop appropriate solution.",book:{id:"8332",slug:"telehealth",title:"Telehealth",fullTitle:"Telehealth"},signatures:"Surya Bali",authors:null},{id:"45211",title:"The Telemedicine Service Maturity Model: A Framework for the Measurement and Improvement of Telemedicine Services",slug:"the-telemedicine-service-maturity-model-a-framework-for-the-measurement-and-improvement-of-telemedic",totalDownloads:2962,totalCrossrefCites:4,totalDimensionsCites:12,abstract:null,book:{id:"3269",slug:"telemedicine",title:"Telemedicine",fullTitle:"Telemedicine"},signatures:"Liezl van Dyk and Cornelius S.L. Schutte",authors:[{id:"27481",title:"Ms",name:"Liezl",middleName:null,surname:"Van Dyk",slug:"liezl-van-dyk",fullName:"Liezl Van Dyk"},{id:"166270",title:"Prof.",name:"Corne",middleName:null,surname:"Schutte",slug:"corne-schutte",fullName:"Corne Schutte"}]},{id:"45744",title:"PITES: Telemedicine and e-Health Innovation Platform",slug:"pites-telemedicine-and-e-health-innovation-platform",totalDownloads:2038,totalCrossrefCites:0,totalDimensionsCites:3,abstract:null,book:{id:"3269",slug:"telemedicine",title:"Telemedicine",fullTitle:"Telemedicine"},signatures:"José Luis Monteagudo, Mario Pascual, Adolfo Muñoz, Pilar G.\nSagredo, Ricardo Sánchez de Madariaga and Carlos H. Salvador",authors:[{id:"16290",title:"Dr.",name:"Jose Luis",middleName:null,surname:"Monteagudo",slug:"jose-luis-monteagudo",fullName:"Jose Luis Monteagudo"},{id:"157901",title:"Dr.",name:"Mario",middleName:null,surname:"Pascual",slug:"mario-pascual",fullName:"Mario Pascual"},{id:"157902",title:"Dr.",name:"Adolfo",middleName:null,surname:"Muñoz",slug:"adolfo-munoz",fullName:"Adolfo Muñoz"},{id:"157903",title:"Mrs.",name:"Pilar",middleName:null,surname:"Sagredo",slug:"pilar-sagredo",fullName:"Pilar Sagredo"},{id:"157904",title:"Dr.",name:"Ricardo",middleName:null,surname:"Sánchez De Madariaga",slug:"ricardo-sanchez-de-madariaga",fullName:"Ricardo Sánchez De Madariaga"},{id:"157906",title:"Dr.",name:"Carlos",middleName:null,surname:"Hernandez Salvador",slug:"carlos-hernandez-salvador",fullName:"Carlos Hernandez Salvador"}]},{id:"38846",title:"Advances and Perspectives in the Field of Auscultation, with a Special Focus on the Contribution of New Intelligent Communicating Stethoscope Systems in Clinical Practice, in Teaching and Telemedicine",slug:"advances-and-perspectives-in-the-field-of-auscultation-with-a-special-focus-on-the-contribution-of-n",totalDownloads:3911,totalCrossrefCites:4,totalDimensionsCites:8,abstract:null,book:{id:"2824",slug:"ehealth-and-remote-monitoring",title:"eHealth and Remote Monitoring",fullTitle:"eHealth and Remote Monitoring"},signatures:"Emmanuel Andrès",authors:[{id:"143493",title:"Prof.",name:"Emmanuel",middleName:null,surname:"Andrès",slug:"emmanuel-andres",fullName:"Emmanuel Andrès"}]},{id:"63541",title:"The Advent of Application Specific Integrated Circuits (ASIC)-MEMS within the Medical System",slug:"the-advent-of-application-specific-integrated-circuits-asic-mems-within-the-medical-system",totalDownloads:1185,totalCrossrefCites:0,totalDimensionsCites:1,abstract:"Medical healthcare has become one of the fastest growing and largest industries in the world. More and more people are aware of the precious and important life. At the same time, personal disposable income increases and awareness of disease prevention increases. It allows the healthcare industry to maintain high growth rates. Micro-electro- mechanical systems (MEMS) is one of the most revolutionary semiconductor components. The advent of Application Specific Integrated Circuits (ASIC)-MEMS has created a new era for the healthcare industry. The medical Micro LED detects the blood vessel position with the emission light source and repositions the blood flow state of the blood vessel. Micro LED mainly uses the MEMS micro-fabrication technology to micronize, array, and thin film the traditional LED crystal film. This article will explore how to use MEMS wafers to redefine the needs of the healthcare market and open up new growth opportunities for healthcare applications. With the shift from first-hand medical devices from the hospital business to personal use, miniaturization, economics, reliability and battery life have become new demands in the healthcare market.",book:{id:"8332",slug:"telehealth",title:"Telehealth",fullTitle:"Telehealth"},signatures:"Jian-Chiun Liou",authors:[{id:"222901",title:"Prof.",name:"Jian-Chiun",middleName:null,surname:"Liou",slug:"jian-chiun-liou",fullName:"Jian-Chiun Liou"}]}],onlineFirstChaptersFilter:{topicId:"203",limit:6,offset:0},onlineFirstChaptersCollection:[],onlineFirstChaptersTotal:0},preDownload:{success:null,errors:{}},subscriptionForm:{success:null,errors:{}},aboutIntechopen:{},privacyPolicy:{},peerReviewing:{},howOpenAccessPublishingWithIntechopenWorks:{},sponsorshipBooks:{sponsorshipBooks:[],offset:8,limit:8,total:0},allSeries:{pteSeriesList:[{id:"14",title:"Artificial Intelligence",numberOfPublishedBooks:9,numberOfPublishedChapters:89,numberOfOpenTopics:6,numberOfUpcomingTopics:0,issn:"2633-1403",doi:"10.5772/intechopen.79920",isOpenForSubmission:!0},{id:"7",title:"Biomedical Engineering",numberOfPublishedBooks:12,numberOfPublishedChapters:104,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2631-5343",doi:"10.5772/intechopen.71985",isOpenForSubmission:!0}],lsSeriesList:[{id:"11",title:"Biochemistry",numberOfPublishedBooks:32,numberOfPublishedChapters:318,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2632-0983",doi:"10.5772/intechopen.72877",isOpenForSubmission:!0},{id:"25",title:"Environmental Sciences",numberOfPublishedBooks:1,numberOfPublishedChapters:12,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2754-6713",doi:"10.5772/intechopen.100362",isOpenForSubmission:!0},{id:"10",title:"Physiology",numberOfPublishedBooks:11,numberOfPublishedChapters:141,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2631-8261",doi:"10.5772/intechopen.72796",isOpenForSubmission:!0}],hsSeriesList:[{id:"3",title:"Dentistry",numberOfPublishedBooks:8,numberOfPublishedChapters:129,numberOfOpenTopics:2,numberOfUpcomingTopics:0,issn:"2631-6218",doi:"10.5772/intechopen.71199",isOpenForSubmission:!0},{id:"6",title:"Infectious Diseases",numberOfPublishedBooks:13,numberOfPublishedChapters:113,numberOfOpenTopics:3,numberOfUpcomingTopics:1,issn:"2631-6188",doi:"10.5772/intechopen.71852",isOpenForSubmission:!0},{id:"13",title:"Veterinary Medicine and Science",numberOfPublishedBooks:11,numberOfPublishedChapters:106,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2632-0517",doi:"10.5772/intechopen.73681",isOpenForSubmission:!0}],sshSeriesList:[{id:"22",title:"Business, Management and Economics",numberOfPublishedBooks:1,numberOfPublishedChapters:19,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2753-894X",doi:"10.5772/intechopen.100359",isOpenForSubmission:!0},{id:"23",title:"Education and Human Development",numberOfPublishedBooks:0,numberOfPublishedChapters:5,numberOfOpenTopics:1,numberOfUpcomingTopics:1,issn:null,doi:"10.5772/intechopen.100360",isOpenForSubmission:!0},{id:"24",title:"Sustainable Development",numberOfPublishedBooks:0,numberOfPublishedChapters:15,numberOfOpenTopics:5,numberOfUpcomingTopics:0,issn:null,doi:"10.5772/intechopen.100361",isOpenForSubmission:!0}],testimonialsList:[{id:"13",text:"The collaboration with and support of the technical staff of IntechOpen is fantastic. The whole process of submitting an article and editing of the submitted article goes extremely smooth and fast, the number of reads and downloads of chapters is high, and the contributions are also frequently cited.",author:{id:"55578",name:"Antonio",surname:"Jurado-Navas",institutionString:null,profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRisIQAS/Profile_Picture_1626166543950",slug:"antonio-jurado-navas",institution:{id:"720",name:"University of Malaga",country:{id:null,name:"Spain"}}}},{id:"6",text:"It is great to work with the IntechOpen to produce a worthwhile collection of research that also becomes a great educational resource and guide for future research endeavors.",author:{id:"259298",name:"Edward",surname:"Narayan",institutionString:null,profilePictureURL:"https://mts.intechopen.com/storage/users/259298/images/system/259298.jpeg",slug:"edward-narayan",institution:{id:"3",name:"University of Queensland",country:{id:null,name:"Australia"}}}}]},series:{item:{id:"22",title:"Business, Management and Economics",doi:"10.5772/intechopen.100359",issn:"2753-894X",scope:"\r\n\tThis series will provide a comprehensive overview of recent research trends in business and management, economics, and marketing. Topics will include asset liability management, financial consequences of the financial crisis and covid-19, financial accounting, mergers and acquisitions, management accounting, SMEs, financial markets, corporate finance and governance, managerial technology and innovation, resource management and sustainable development, social entrepreneurship, corporate responsibility, ethics and accountability, microeconomics, labour economics, macroeconomics, public economics, financial economics, econometrics, direct marketing, creative marketing, internet marketing, market planning and forecasting, brand management, market segmentation and targeting and other topics under business and management. This book series will focus on various aspects of business and management whose in-depth understanding is critical for business and company management to function effectively during this uncertain time of financial crisis, Covid-19 pandemic, and military activity in Europe.
",coverUrl:"https://cdn.intechopen.com/series/covers/22.jpg",latestPublicationDate:"June 27th, 2022",hasOnlineFirst:!0,numberOfPublishedBooks:1,editor:{id:"356540",title:"Prof.",name:"Taufiq",middleName:null,surname:"Choudhry",slug:"taufiq-choudhry",fullName:"Taufiq Choudhry",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y000036X2hvQAC/Profile_Picture_2022-03-14T08:58:03.jpg",biography:"Prof. Choudhry holds a BSc degree in Economics from the University of Iowa, as well as a Masters and Ph.D. in Applied Economics from Clemson University, USA. In January 2006, he became a Professor of Finance at the University of Southampton Business School. He was previously a Professor of Finance at the University of Bradford Management School. He has over 80 articles published in international finance and economics journals. His research interests and specialties include financial econometrics, financial economics, international economics and finance, housing markets, financial markets, among others.",institutionString:null,institution:{name:"University of Southampton",institutionURL:null,country:{name:"United Kingdom"}}},editorTwo:null,editorThree:null},subseries:{paginationCount:3,paginationItems:[{id:"86",title:"Business and Management",coverUrl:"https://cdn.intechopen.com/series_topics/covers/86.jpg",isOpenForSubmission:!0,editor:{id:"128342",title:"Prof.",name:"Vito",middleName:null,surname:"Bobek",slug:"vito-bobek",fullName:"Vito Bobek",profilePictureURL:"https://mts.intechopen.com/storage/users/128342/images/system/128342.jpg",biography:"Dr. Vito Bobek works as an international management professor at the University of Applied Sciences FH Joanneum, Graz, Austria. He has published more than 400 works in his academic career and visited twenty-two universities worldwide as a visiting professor. Dr. Bobek is a member of the editorial boards of six international journals and a member of the Strategic Council of the Minister of Foreign Affairs of the Republic of Slovenia. He has a long history in academia, consulting, and entrepreneurship. His own consulting firm, Palemid, has managed twenty significant projects, such as Cooperation Program Interreg V-A (Slovenia-Austria) and Capacity Building for the Serbian Chamber of Enforcement Agents. He has also participated in many international projects in Italy, Germany, Great Britain, the United States, Spain, Turkey, France, Romania, Croatia, Montenegro, Malaysia, and China. Dr. Bobek is also a co-founder of the Academy of Regional Management in Slovenia.",institutionString:"Universities of Applied Sciences FH Joanneum, Austria",institution:null},editorTwo:{id:"293992",title:"Dr.",name:"Tatjana",middleName:null,surname:"Horvat",slug:"tatjana-horvat",fullName:"Tatjana Horvat",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002hXb0hQAC/Profile_Picture_1642419002203",biography:"Tatjana Horvat works as a professor for accountant and auditing at the University of Primorska, Slovenia. She is a Certified State Internal Auditor (licensed by Ministry of Finance RS) and Certified Internal Auditor for Business Sector and Certified accountant (licensed by Slovenian Institute of Auditors). At the Ministry of Justice of Slovenia, she is a member of examination boards for court expert candidates and judicial appraisers in the following areas: economy/finance, valuation of companies, banking, and forensic investigation of economic operations/accounting. At the leading business newspaper Finance in Slovenia (Swedish ownership), she is the editor and head of the area for business, finance, tax-related articles, and educational programs.",institutionString:null,institution:{name:"University of Primorska",institutionURL:null,country:{name:"Slovenia"}}},editorThree:null},{id:"87",title:"Economics",coverUrl:"https://cdn.intechopen.com/series_topics/covers/87.jpg",isOpenForSubmission:!0,editor:{id:"327730",title:"Prof.",name:"Jaime",middleName:null,surname:"Ortiz",slug:"jaime-ortiz",fullName:"Jaime Ortiz",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y00002zaOKZQA2/Profile_Picture_1642145584421",biography:"Dr. Jaime Ortiz holds degrees from Chile, the Netherlands, and the United States. He has held tenured faculty, distinguished professorship, and executive leadership appointments in several universities around the world. Dr. Ortiz has previously worked for international organizations and non-government entities in economic and business matters, and he has university-wide globalization engagement in more than thirty-six countries. He has advised, among others, the United Nations Development Program, Inter-American Development Bank, Organization of American States, Pre-investment Organization of Latin America and the Caribbean, Technical Cooperation of the Suisse Government, and the World Bank. Dr. Ortiz is the author, co-author, or editor of books, book chapters, textbooks, research monographs and technical reports, and refereed journal articles. He is listed in Who’s Who in the World, Who’s Who in America, Who’s Who in Finance and Business, Who’s Who in Business Higher Education, Who’s Who in American Education, and Who’s Who Directory of Economists. Dr. Ortiz has been a Fulbright Scholar and an MSI Leadership Fellow with the W.K. Kellogg Foundation. His teaching interests revolve around global economies and markets while his research focuses on topics related to development and growth, global business decisions, and the economics of technical innovation.",institutionString:null,institution:{name:"University of Houston",institutionURL:null,country:{name:"United States of America"}}},editorTwo:null,editorThree:null},{id:"88",title:"Marketing",coverUrl:"https://cdn.intechopen.com/series_topics/covers/88.jpg",isOpenForSubmission:!0,editor:{id:"203609",title:"Associate Prof.",name:"Hanna",middleName:null,surname:"Gorska-Warsewicz",slug:"hanna-gorska-warsewicz",fullName:"Hanna Gorska-Warsewicz",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bSD9pQAG/Profile_Picture_2022-06-14T11:58:32.jpeg",biography:"Hanna Górska-Warsewicz, Ph.D. is Associate Professor at Warsaw University of Life Sciences and Head of Department of Food Market and Consumption Research. She specializes in the subject of brands, brand equity, and brand management in production, service, and trade enterprises. She combines this subject with marketing and marketing management in both theoretical and practical aspects. Prof. Hanna Górska-Warsewicz also analyzes brands in the context of trademarks, legal regulations and the protection of intangible. She is an author or co-author of over 200 publications in this field, including 8 books. She works with the business sector and has participated in projects for the Ministry of Agriculture and Rural Development and the Ministry of Education and Science in Poland.",institutionString:null,institution:{name:"Warsaw University of Life Sciences",institutionURL:null,country:{name:"Poland"}}},editorTwo:null,editorThree:null}]},overviewPageOFChapters:{paginationCount:8,paginationItems:[{id:"82289",title:"Consumer Culture and Abundance of Choices: Having More, Feeling Blue",doi:"10.5772/intechopen.105607",signatures:"Ondřej Roubal",slug:"consumer-culture-and-abundance-of-choices-having-more-feeling-blue",totalDownloads:2,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"A New Era of Consumer Behavior - Beyond the Pandemic",coverURL:"https://cdn.intechopen.com/books/images_new/11581.jpg",subseries:{id:"88",title:"Marketing"}}},{id:"82405",title:"Does Board Structure Matter in CSR Spending of Commercial Banks? Empirical Evidence from an Emerging Economy",doi:"10.5772/intechopen.105589",signatures:"Bishnu Kumar Adhikary and Ranjan Kumar Mitra",slug:"does-board-structure-matter-in-csr-spending-of-commercial-banks-empirical-evidence-from-an-emerging-",totalDownloads:7,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Corporate Social Responsibility",coverURL:"https://cdn.intechopen.com/books/images_new/11602.jpg",subseries:{id:"86",title:"Business and Management"}}},{id:"82395",title:"Toward a Better Understanding of Green Human Resource Management’s Impact on Green Competitive Advantage: A Conceptual Model",doi:"10.5772/intechopen.105528",signatures:"Hosna Hossari and Kaoutar Elfahli",slug:"toward-a-better-understanding-of-green-human-resource-management-s-impact-on-green-competitive-advan",totalDownloads:12,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Corporate Social Responsibility",coverURL:"https://cdn.intechopen.com/books/images_new/11602.jpg",subseries:{id:"86",title:"Business and Management"}}},{id:"82269",title:"CSR Reporting and Blockchain Technology",doi:"10.5772/intechopen.105512",signatures:"Pattarake Sarajoti, Pattanaporn Chatjuthamard, Suwongrat Papangkorn and Piyachart Phiromswad",slug:"csr-reporting-and-blockchain-technology",totalDownloads:9,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Corporate Social Responsibility",coverURL:"https://cdn.intechopen.com/books/images_new/11602.jpg",subseries:{id:"86",title:"Business and Management"}}}]},overviewPagePublishedBooks:{paginationCount:1,paginationItems:[{type:"book",id:"11392",title:"Leadership in a Changing World",subtitle:"A Multidimensional Perspective",coverURL:"https://cdn.intechopen.com/books/images_new/11392.jpg",slug:"leadership-in-a-changing-world-a-multidimensional-perspective",publishedDate:"May 11th 2022",editedByType:"Edited by",bookSignature:"Muhammad Mohiuddin, Bilal Khalid, Md. Samim Al Azad and Slimane Ed-dafali",hash:"86a6d33cf601587e591064ce92effc02",volumeInSeries:1,fullTitle:"Leadership in a Changing World - A Multidimensional Perspective",editors:[{id:"418514",title:"Dr.",name:"Muhammad",middleName:null,surname:"Mohiuddin",slug:"muhammad-mohiuddin",fullName:"Muhammad Mohiuddin",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y000038UqSfQAK/Profile_Picture_2022-05-13T10:39:03.jpg",biography:"Dr. Muhammad Mohiuddin is an Associate Professor of International Business at Laval University, Canada. He has taught at Thompson Rivers University, Canada; University of Paris-Est, France; Osnabruck University of Applied Science, Germany; and Shanghai Institute of Technology and Tianjin University of Technology, China. He has published research in Research Policy, Applied Economics, Review of Economic Philosophy, Strategic Change, International Journal of Logistics, Sustainability, Journal of Environmental Management, Journal of Global Information Management, Journal of Cleaner Production, M@N@GEMENT, and more. He is a member of CEDIMES Institut (France), Academy of International Business (AIB), Strategic Management Society (SMS), Academy of Management (AOM), Administrative Science Association of Canada (ASAC), and Canadian council of small business and entrepreneurship (CCSBE). He is currently the director of the Research Group on Contemporary Asia (GERAC) at Laval University. He is also co-managing editor of Transnational Corporations Review and a guest editor for Electronic Commerce Research and Journal of Internet Technology.",institutionString:"Université Laval",institution:{name:"Université Laval",institutionURL:null,country:{name:"Canada"}}}]}]},openForSubmissionBooks:{paginationCount:3,paginationItems:[{id:"11578",title:"Antibiotics and Probiotics in Animal Food - Impact and Regulation",coverURL:"https://cdn.intechopen.com/books/images_new/11578.jpg",hash:"3731c009f474c6ed4293f348ca7b27ac",secondStepPassed:!0,currentStepOfPublishingProcess:3,submissionDeadline:"June 3rd 2022",isOpenForSubmission:!0,editors:[{id:"225390",title:"Dr.",name:"Asghar Ali",surname:"Kamboh",slug:"asghar-ali-kamboh",fullName:"Asghar Ali Kamboh"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{id:"12086",title:"Cattle Diseases - Molecular and Biochemical Approach",coverURL:"https://cdn.intechopen.com/books/images_new/12086.jpg",hash:"afdbf57e32d996556a94528c06623cf3",secondStepPassed:!1,currentStepOfPublishingProcess:2,submissionDeadline:"July 5th 2022",isOpenForSubmission:!0,editors:[{id:"219081",title:"Dr.",name:"Abdulsamed",surname:"Kükürt",slug:"abdulsamed-kukurt",fullName:"Abdulsamed Kükürt"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{id:"11579",title:"Animal Welfare - New Insights",coverURL:"https://cdn.intechopen.com/books/images_new/11579.jpg",hash:"12e4f41264cbe99028655e5463fa941a",secondStepPassed:!1,currentStepOfPublishingProcess:2,submissionDeadline:"July 8th 2022",isOpenForSubmission:!0,editors:[{id:"51520",title:"Dr.",name:"Shao-Wen",surname:"Hung",slug:"shao-wen-hung",fullName:"Shao-Wen Hung"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null}]},onlineFirstChapters:{paginationCount:45,paginationItems:[{id:"82135",title:"Carotenoids in Cassava (Manihot esculenta Crantz)",doi:"10.5772/intechopen.105210",signatures:"Lovina I. Udoh, Josephine U. Agogbua, Eberechi R. Keyagha and Itorobong I. Nkanga",slug:"carotenoids-in-cassava-manihot-esculenta-crantz",totalDownloads:7,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Carotenoids - New Perspectives and Application",coverURL:"https://cdn.intechopen.com/books/images_new/10836.jpg",subseries:{id:"13",title:"Plant Physiology"}}},{id:"82112",title:"Comparative Senescence and Lifespan",doi:"10.5772/intechopen.105137",signatures:"Hassan M. Heshmati",slug:"comparative-senescence-and-lifespan",totalDownloads:8,totalCrossrefCites:0,totalDimensionsCites:0,authors:[{name:"Hassan M.",surname:"Heshmati"}],book:{title:"Mechanisms and Management of Senescence",coverURL:"https://cdn.intechopen.com/books/images_new/10935.jpg",subseries:{id:"11",title:"Cell Physiology"}}},{id:"81796",title:"Apoptosis-Related Diseases and Peroxisomes",doi:"10.5772/intechopen.105052",signatures:"Meimei Wang, Yakun Liu, Ni Chen, Juan Wang and Ye Zhao",slug:"apoptosis-related-diseases-and-peroxisomes",totalDownloads:11,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"The Metabolic Role of Peroxisome in Health and Disease",coverURL:"https://cdn.intechopen.com/books/images_new/10837.jpg",subseries:{id:"11",title:"Cell Physiology"}}},{id:"81723",title:"Peroxisomal Modulation as Therapeutic Alternative for Tackling Multiple Cancers",doi:"10.5772/intechopen.104873",signatures:"Shazia Usmani, Shadma Wahab, Abdul Hafeez, Shabana Khatoon and Syed Misbahul Hasan",slug:"peroxisomal-modulation-as-therapeutic-alternative-for-tackling-multiple-cancers",totalDownloads:4,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"The Metabolic Role of Peroxisome in Health and Disease",coverURL:"https://cdn.intechopen.com/books/images_new/10837.jpg",subseries:{id:"11",title:"Cell Physiology"}}},{id:"81638",title:"Aging and Neuropsychiatric Disease: A General Overview of Prevalence and Trends",doi:"10.5772/intechopen.103102",signatures:"Jelena Milić",slug:"aging-and-neuropsychiatric-disease-a-general-overview-of-prevalence-and-trends",totalDownloads:25,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Mechanisms and Management of Senescence",coverURL:"https://cdn.intechopen.com/books/images_new/10935.jpg",subseries:{id:"11",title:"Cell Physiology"}}},{id:"81566",title:"New and Emerging Technologies for Integrative Ambulatory Autonomic Assessment and Intervention as a Catalyst in the Synergy of Remote Geocoded Biosensing, Algorithmic Networked Cloud Computing, Deep Learning, and Regenerative/Biomic Medicine: Further Real",doi:"10.5772/intechopen.104092",signatures:"Robert L. Drury",slug:"new-and-emerging-technologies-for-integrative-ambulatory-autonomic-assessment-and-intervention-as-a-",totalDownloads:17,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Autonomic Nervous System - Special Interest Topics",coverURL:"https://cdn.intechopen.com/books/images_new/10835.jpg",subseries:{id:"12",title:"Human Physiology"}}},{id:"81576",title:"Carotenoids in Thermal Adaptation of Plants and Animals",doi:"10.5772/intechopen.104537",signatures:"Ivan M. Petyaev",slug:"carotenoids-in-thermal-adaptation-of-plants-and-animals",totalDownloads:24,totalCrossrefCites:0,totalDimensionsCites:0,authors:[{name:"Ivan",surname:"Petyaev"}],book:{title:"Carotenoids - New Perspectives and Application",coverURL:"https://cdn.intechopen.com/books/images_new/10836.jpg",subseries:{id:"13",title:"Plant Physiology"}}},{id:"81358",title:"New Insights on Carotenoid Production by Gordonia alkanivorans Strain 1B",doi:"10.5772/intechopen.103919",signatures:"Tiago P. Silva, Susana M. Paixão, Ana S. Fernandes, José C. Roseiro and Luís Alves",slug:"new-insights-on-carotenoid-production-by-gordonia-alkanivorans-strain-1b",totalDownloads:16,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Carotenoids - New Perspectives and Application",coverURL:"https://cdn.intechopen.com/books/images_new/10836.jpg",subseries:{id:"13",title:"Plant Physiology"}}},{id:"81298",title:"Roles of Extracellular Vesicles in Cancer Metastasis",doi:"10.5772/intechopen.103798",signatures:"Eman Helmy Thabet",slug:"roles-of-extracellular-vesicles-in-cancer-metastasis",totalDownloads:36,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Extracellular Vesicles - Role in Diseases, Pathogenesis and Therapy",coverURL:"https://cdn.intechopen.com/books/images_new/10796.jpg",subseries:{id:"11",title:"Cell Physiology"}}},{id:"81290",title:"Musculoskeletal Abnormalities Caused by Cystic Fibrosis",doi:"10.5772/intechopen.104591",signatures:"Mark Lambrechts",slug:"musculoskeletal-abnormalities-caused-by-cystic-fibrosis",totalDownloads:24,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Advances in Skeletal Muscle Health and Disease",coverURL:"https://cdn.intechopen.com/books/images_new/11675.jpg",subseries:{id:"11",title:"Cell Physiology"}}}]},subseriesFiltersForOFChapters:[{caption:"Plant Physiology",value:13,count:6,group:"subseries"},{caption:"Human Physiology",value:12,count:13,group:"subseries"},{caption:"Cell Physiology",value:11,count:26,group:"subseries"}],publishedBooks:{paginationCount:1,paginationItems:[{type:"book",id:"10843",title:"Persistent Organic Pollutants (POPs)",subtitle:"Monitoring, Impact and Treatment",coverURL:"https://cdn.intechopen.com/books/images_new/10843.jpg",slug:"persistent-organic-pollutants-pops-monitoring-impact-and-treatment",publishedDate:"April 13th 2022",editedByType:"Edited by",bookSignature:"Mohamed Nageeb Rashed",hash:"f5b1589f0a990b6114fef2dadc735dd9",volumeInSeries:1,fullTitle:"Persistent Organic Pollutants (POPs) - Monitoring, Impact and Treatment",editors:[{id:"63465",title:"Prof.",name:"Mohamed Nageeb",middleName:null,surname:"Rashed",slug:"mohamed-nageeb-rashed",fullName:"Mohamed Nageeb Rashed",profilePictureURL:"https://mts.intechopen.com/storage/users/63465/images/system/63465.gif",institutionString:null,institution:{name:"Aswan University",institutionURL:null,country:{name:"Egypt"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null}]},subseriesFiltersForPublishedBooks:[{group:"subseries",caption:"Pollution",value:38,count:1}],publicationYearFilters:[{group:"publicationYear",caption:"2022",value:2022,count:1}],authors:{paginationCount:0,paginationItems:[]}},subseries:{item:{id:"22",type:"subseries",title:"Applied Intelligence",keywords:"Machine Learning, Intelligence Algorithms, Data Science, Artificial Intelligence, Applications on Applied Intelligence",scope:"This field is the key in the current industrial revolution (Industry 4.0), where the new models and developments are based on the knowledge generation on applied intelligence. The motor of the society is the industry and the research of this topic has to be empowered in order to increase and improve the quality of our lives.",coverUrl:"https://cdn.intechopen.com/series_topics/covers/22.jpg",hasOnlineFirst:!0,hasPublishedBooks:!0,annualVolume:11418,editor:{id:"27170",title:"Prof.",name:"Carlos",middleName:"M.",surname:"Travieso-Gonzalez",slug:"carlos-travieso-gonzalez",fullName:"Carlos Travieso-Gonzalez",profilePictureURL:"https://mts.intechopen.com/storage/users/27170/images/system/27170.jpeg",biography:"Carlos M. Travieso-González received his MSc degree in Telecommunication Engineering at Polytechnic University of Catalonia (UPC), Spain in 1997, and his Ph.D. degree in 2002 at the University of Las Palmas de Gran Canaria (ULPGC-Spain). He is a full professor of signal processing and pattern recognition and is head of the Signals and Communications Department at ULPGC, teaching from 2001 on subjects on signal processing and learning theory. His research lines are biometrics, biomedical signals and images, data mining, classification system, signal and image processing, machine learning, and environmental intelligence. He has researched in 52 international and Spanish research projects, some of them as head researcher. He is co-author of 4 books, co-editor of 27 proceedings books, guest editor for 8 JCR-ISI international journals, and up to 24 book chapters. He has over 450 papers published in international journals and conferences (81 of them indexed on JCR – ISI - Web of Science). He has published seven patents in the Spanish Patent and Trademark Office. He has been a supervisor on 8 Ph.D. theses (11 more are under supervision), and 130 master theses. He is the founder of The IEEE IWOBI conference series and the president of its Steering Committee, as well as the founder of both the InnoEducaTIC and APPIS conference series. He is an evaluator of project proposals for the European Union (H2020), Medical Research Council (MRC, UK), Spanish Government (ANECA, Spain), Research National Agency (ANR, France), DAAD (Germany), Argentinian Government, and the Colombian Institutions. He has been a reviewer in different indexed international journals (<70) and conferences (<250) since 2001. He has been a member of the IASTED Technical Committee on Image Processing from 2007 and a member of the IASTED Technical Committee on Artificial Intelligence and Expert Systems from 2011. \n\nHe has held the general chair position for the following: ACM-APPIS (2020, 2021), IEEE-IWOBI (2019, 2020 and 2020), A PPIS (2018, 2019), IEEE-IWOBI (2014, 2015, 2017, 2018), InnoEducaTIC (2014, 2017), IEEE-INES (2013), NoLISP (2011), JRBP (2012), and IEEE-ICCST (2005)\n\nHe is an associate editor of the Computational Intelligence and Neuroscience Journal (Hindawi – Q2 JCR-ISI). He was vice dean from 2004 to 2010 in the Higher Technical School of Telecommunication Engineers at ULPGC and the vice dean of Graduate and Postgraduate Studies from March 2013 to November 2017. He won the “Catedra Telefonica” Awards in Modality of Knowledge Transfer, 2017, 2018, and 2019 editions, and awards in Modality of COVID Research in 2020.\n\nPublic References:\nResearcher ID http://www.researcherid.com/rid/N-5967-2014\nORCID https://orcid.org/0000-0002-4621-2768 \nScopus Author ID https://www.scopus.com/authid/detail.uri?authorId=6602376272\nScholar Google https://scholar.google.es/citations?user=G1ks9nIAAAAJ&hl=en \nResearchGate https://www.researchgate.net/profile/Carlos_Travieso",institutionString:null,institution:{name:"University of Las Palmas de Gran Canaria",institutionURL:null,country:{name:"Spain"}}},editorTwo:null,editorThree:null,series:{id:"14",title:"Artificial Intelligence",doi:"10.5772/intechopen.79920",issn:"2633-1403"},editorialBoard:[{id:"13633",title:"Prof.",name:"Abdelhamid",middleName:null,surname:"Mellouk",slug:"abdelhamid-mellouk",fullName:"Abdelhamid Mellouk",profilePictureURL:"https://mts.intechopen.com/storage/users/13633/images/1567_n.jpg",institutionString:null,institution:{name:"Paris 12 Val de Marne University",institutionURL:null,country:{name:"France"}}},{id:"109268",title:"Dr.",name:"Ali",middleName:null,surname:"Al-Ataby",slug:"ali-al-ataby",fullName:"Ali Al-Ataby",profilePictureURL:"https://mts.intechopen.com/storage/users/109268/images/7410_n.jpg",institutionString:null,institution:{name:"University of Liverpool",institutionURL:null,country:{name:"United Kingdom"}}},{id:"3807",title:"Dr.",name:"Carmelo",middleName:"Jose Albanez",surname:"Bastos-Filho",slug:"carmelo-bastos-filho",fullName:"Carmelo Bastos-Filho",profilePictureURL:"https://mts.intechopen.com/storage/users/3807/images/624_n.jpg",institutionString:null,institution:{name:"Universidade de Pernambuco",institutionURL:null,country:{name:"Brazil"}}},{id:"38850",title:"Dr.",name:"Efren",middleName:null,surname:"Gorrostieta Hurtado",slug:"efren-gorrostieta-hurtado",fullName:"Efren Gorrostieta Hurtado",profilePictureURL:"https://mts.intechopen.com/storage/users/38850/images/system/38850.jpg",institutionString:null,institution:{name:"Autonomous University of Queretaro",institutionURL:null,country:{name:"Mexico"}}},{id:"239041",title:"Prof.",name:"Yang",middleName:null,surname:"Yi",slug:"yang-yi",fullName:"Yang Yi",profilePictureURL:"https://mts.intechopen.com/storage/users/239041/images/system/239041.jpeg",institutionString:"Virginia Tech",institution:{name:"Virginia Tech",institutionURL:null,country:{name:"United States of America"}}}]},onlineFirstChapters:{paginationCount:1,paginationItems:[{id:"82380",title:"Evolution of Parasitism and Pathogenic Adaptations in Certain Medically Important Fungi",doi:"10.5772/intechopen.105206",signatures:"Gokul Shankar Sabesan, Ranjit Singh AJA, Ranjith Mehenderkar and Basanta Kumar Mohanty",slug:"evolution-of-parasitism-and-pathogenic-adaptations-in-certain-medically-important-fungi",totalDownloads:4,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Fungal Infectious Diseases - Annual Volume 2022",coverURL:"https://cdn.intechopen.com/books/images_new/11400.jpg",subseries:{id:"4",title:"Fungal Infectious Diseases"}}}]},publishedBooks:{paginationCount:13,paginationItems:[{type:"book",id:"10798",title:"Starch",subtitle:"Evolution and Recent Advances",coverURL:"https://cdn.intechopen.com/books/images_new/10798.jpg",slug:"starch-evolution-and-recent-advances",publishedDate:"June 28th 2022",editedByType:"Edited by",bookSignature:"Martins Ochubiojo Emeje",hash:"f197f6062c1574a9a90e50a369271bcf",volumeInSeries:33,fullTitle:"Starch - Evolution and Recent Advances",editors:[{id:"94311",title:"Prof.",name:"Martins",middleName:"Ochubiojo",surname:"Ochubiojo Emeje",slug:"martins-ochubiojo-emeje",fullName:"Martins Ochubiojo Emeje",profilePictureURL:"https://mts.intechopen.com/storage/users/94311/images/system/94311.jpeg",institutionString:"National Institute for Pharmaceutical Research and Development",institution:{name:"National Institute for Pharmaceutical Research and Development",institutionURL:null,country:{name:"Nigeria"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"11332",title:"Essential Oils",subtitle:"Advances in Extractions and Biological Applications",coverURL:"https://cdn.intechopen.com/books/images_new/11332.jpg",slug:"essential-oils-advances-in-extractions-and-biological-applications",publishedDate:"June 23rd 2022",editedByType:"Edited by",bookSignature:"Mozaniel Santana de Oliveira and Eloisa Helena de Aguiar Andrade",hash:"742e6cae3a35686f975edc8d7f9afa94",volumeInSeries:32,fullTitle:"Essential Oils - Advances in Extractions and Biological Applications",editors:[{id:"195290",title:"Ph.D.",name:"Mozaniel",middleName:null,surname:"Santana De Oliveira",slug:"mozaniel-santana-de-oliveira",fullName:"Mozaniel Santana De Oliveira",profilePictureURL:"https://mts.intechopen.com/storage/users/195290/images/system/195290.png",institutionString:"Museu Paraense Emílio Goeldi",institution:{name:"Museu Paraense Emílio Goeldi",institutionURL:null,country:{name:"Brazil"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"10841",title:"Hydrolases",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/10841.jpg",slug:"hydrolases",publishedDate:"June 15th 2022",editedByType:"Edited by",bookSignature:"Sajjad Haider, Adnan Haider and Angel Catalá",hash:"4e868cde273d65a7ff54b1817d640629",volumeInSeries:29,fullTitle:"Hydrolases",editors:[{id:"110708",title:"Dr.",name:"Sajjad",middleName:null,surname:"Haider",slug:"sajjad-haider",fullName:"Sajjad Haider",profilePictureURL:"https://mts.intechopen.com/storage/users/110708/images/system/110708.png",institutionString:"King Saud University",institution:{name:"King Saud University",institutionURL:null,country:{name:"Saudi Arabia"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"10799",title:"Phenolic Compounds",subtitle:"Chemistry, Synthesis, Diversity, Non-Conventional Industrial, Pharmaceutical and Therapeutic Applications",coverURL:"https://cdn.intechopen.com/books/images_new/10799.jpg",slug:"phenolic-compounds-chemistry-synthesis-diversity-non-conventional-industrial-pharmaceutical-and-therapeutic-applications",publishedDate:"February 23rd 2022",editedByType:"Edited by",bookSignature:"Farid A. Badria",hash:"339199f254d2987ef3167eef74fb8a38",volumeInSeries:26,fullTitle:"Phenolic Compounds - Chemistry, Synthesis, Diversity, Non-Conventional Industrial, Pharmaceutical and Therapeutic Applications",editors:[{id:"41865",title:"Prof.",name:"Farid A.",middleName:null,surname:"Badria",slug:"farid-a.-badria",fullName:"Farid A. Badria",profilePictureURL:"https://mts.intechopen.com/storage/users/41865/images/system/41865.jpg",institutionString:"Mansoura University",institution:{name:"Mansoura University",institutionURL:null,country:{name:"Egypt"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"9753",title:"Terpenes and Terpenoids",subtitle:"Recent Advances",coverURL:"https://cdn.intechopen.com/books/images_new/9753.jpg",slug:"terpenes-and-terpenoids-recent-advances",publishedDate:"July 28th 2021",editedByType:"Edited by",bookSignature:"Shagufta Perveen and Areej Mohammad Al-Taweel",hash:"575689df13c78bf0e6c1be40804cd010",volumeInSeries:21,fullTitle:"Terpenes and Terpenoids - Recent Advances",editors:[{id:"192992",title:"Prof.",name:"Shagufta",middleName:null,surname:"Perveen",slug:"shagufta-perveen",fullName:"Shagufta Perveen",profilePictureURL:"https://mts.intechopen.com/storage/users/192992/images/system/192992.png",institutionString:"King Saud University",institution:{name:"King Saud University",institutionURL:null,country:{name:"Saudi Arabia"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"9731",title:"Oxidoreductase",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/9731.jpg",slug:"oxidoreductase",publishedDate:"February 17th 2021",editedByType:"Edited by",bookSignature:"Mahmoud Ahmed Mansour",hash:"852e6f862c85fc3adecdbaf822e64e6e",volumeInSeries:19,fullTitle:"Oxidoreductase",editors:[{id:"224662",title:"Prof.",name:"Mahmoud Ahmed",middleName:null,surname:"Mansour",slug:"mahmoud-ahmed-mansour",fullName:"Mahmoud Ahmed Mansour",profilePictureURL:"https://mts.intechopen.com/storage/users/224662/images/system/224662.jpg",institutionString:"King Saud bin Abdulaziz University for Health Sciences",institution:{name:"King Saud bin Abdulaziz University for Health Sciences",institutionURL:null,country:{name:"Saudi Arabia"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"8094",title:"Aflatoxin B1 Occurrence, Detection and Toxicological Effects",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/8094.jpg",slug:"aflatoxin-b1-occurrence-detection-and-toxicological-effects",publishedDate:"June 3rd 2020",editedByType:"Edited by",bookSignature:"Xi-Dai Long",hash:"44f4ad52d8a8cbb22ef3d505d6b18027",volumeInSeries:14,fullTitle:"Aflatoxin B1 Occurrence, Detection and Toxicological Effects",editors:[{id:"202142",title:"Prof.",name:"Xi-Dai",middleName:null,surname:"Long",slug:"xi-dai-long",fullName:"Xi-Dai Long",profilePictureURL:"https://mts.intechopen.com/storage/users/202142/images/system/202142.jpeg",institutionString:"Youjiang Medical University for Nationalities",institution:null}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"8004",title:"Nitrogen Fixation",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/8004.jpg",slug:"nitrogen-fixation",publishedDate:"April 8th 2020",editedByType:"Edited by",bookSignature:"Everlon Cid Rigobelo and Ademar Pereira Serra",hash:"02f39c8365ba155d1c520184c2f26976",volumeInSeries:11,fullTitle:"Nitrogen Fixation",editors:[{id:"39553",title:"Prof.",name:"Everlon",middleName:"Cid",surname:"Rigobelo",slug:"everlon-rigobelo",fullName:"Everlon Rigobelo",profilePictureURL:"https://mts.intechopen.com/storage/users/39553/images/system/39553.jpg",institutionString:"São Paulo State University",institution:{name:"Sao Paulo State University",institutionURL:null,country:{name:"Brazil"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"8028",title:"Flavonoids",subtitle:"A Coloring Model for Cheering up Life",coverURL:"https://cdn.intechopen.com/books/images_new/8028.jpg",slug:"flavonoids-a-coloring-model-for-cheering-up-life",publishedDate:"March 11th 2020",editedByType:"Edited by",bookSignature:"Farid A. Badria and Anthony Ananga",hash:"6c33178a5c7d2b276d2c6af4255def64",volumeInSeries:10,fullTitle:"Flavonoids - A Coloring Model for Cheering up Life",editors:[{id:"41865",title:"Prof.",name:"Farid A.",middleName:null,surname:"Badria",slug:"farid-a.-badria",fullName:"Farid A. Badria",profilePictureURL:"https://mts.intechopen.com/storage/users/41865/images/system/41865.jpg",institutionString:"Mansoura University",institution:{name:"Mansoura University",institutionURL:null,country:{name:"Egypt"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"8170",title:"Chemical Properties of Starch",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/8170.jpg",slug:"chemical-properties-of-starch",publishedDate:"March 11th 2020",editedByType:"Edited by",bookSignature:"Martins Emeje",hash:"0aedfdb374631bb3a33870c4ed16559a",volumeInSeries:9,fullTitle:"Chemical Properties of Starch",editors:[{id:"94311",title:"Prof.",name:"Martins",middleName:"Ochubiojo",surname:"Ochubiojo Emeje",slug:"martins-ochubiojo-emeje",fullName:"Martins Ochubiojo Emeje",profilePictureURL:"https://mts.intechopen.com/storage/users/94311/images/system/94311.jpeg",institutionString:"National Institute for Pharmaceutical Research and Development",institution:{name:"National Institute for Pharmaceutical Research and Development",institutionURL:null,country:{name:"Nigeria"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"8019",title:"Alginates",subtitle:"Recent Uses of This Natural Polymer",coverURL:"https://cdn.intechopen.com/books/images_new/8019.jpg",slug:"alginates-recent-uses-of-this-natural-polymer",publishedDate:"February 5th 2020",editedByType:"Edited by",bookSignature:"Leonel Pereira",hash:"61ea5c1aef462684a3b2215631b7dbf2",volumeInSeries:7,fullTitle:"Alginates - Recent Uses of This Natural Polymer",editors:[{id:"279788",title:"Dr.",name:"Leonel",middleName:null,surname:"Pereira",slug:"leonel-pereira",fullName:"Leonel Pereira",profilePictureURL:"https://mts.intechopen.com/storage/users/279788/images/system/279788.jpg",institutionString:"University of Coimbra",institution:{name:"University of Coimbra",institutionURL:null,country:{name:"Portugal"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"8504",title:"Pectins",subtitle:"Extraction, Purification, Characterization and Applications",coverURL:"https://cdn.intechopen.com/books/images_new/8504.jpg",slug:"pectins-extraction-purification-characterization-and-applications",publishedDate:"January 22nd 2020",editedByType:"Edited by",bookSignature:"Martin Masuelli",hash:"ff1acef627b277c575a10b3259dd331b",volumeInSeries:6,fullTitle:"Pectins - Extraction, Purification, Characterization and Applications",editors:[{id:"99994",title:"Dr.",name:"Martin",middleName:"Alberto",surname:"Masuelli",slug:"martin-masuelli",fullName:"Martin Masuelli",profilePictureURL:"https://mts.intechopen.com/storage/users/99994/images/system/99994.png",institutionString:"National University of San Luis",institution:{name:"National University of San Luis",institutionURL:null,country:{name:"Argentina"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null}]},testimonialsList:[{id:"18",text:"It was great publishing with IntechOpen, the process was straightforward and I had support all along.",author:{id:"71579",name:"Berend",surname:"Olivier",institutionString:"Utrecht University",profilePictureURL:"https://mts.intechopen.com/storage/users/71579/images/system/71579.png",slug:"berend-olivier",institution:{id:"253",name:"Utrecht University",country:{id:null,name:"Netherlands"}}}},{id:"27",text:"The opportunity to work with a prestigious publisher allows for the possibility to collaborate with more research groups interested in animal nutrition, leading to the development of new feeding strategies and food valuation while being more sustainable with the environment, allowing more readers to learn about the subject.",author:{id:"175967",name:"Manuel",surname:"Gonzalez Ronquillo",institutionString:null,profilePictureURL:"https://mts.intechopen.com/storage/users/175967/images/system/175967.png",slug:"manuel-gonzalez-ronquillo",institution:{id:"6221",name:"Universidad Autónoma del Estado de México",country:{id:null,name:"Mexico"}}}},{id:"8",text:"I work with IntechOpen for a number of reasons: their professionalism, their mission in support of Open Access publishing, and the quality of their peer-reviewed publications, but also because they believe in equality.",author:{id:"202192",name:"Catrin",surname:"Rutland",institutionString:null,profilePictureURL:"https://mts.intechopen.com/storage/users/202192/images/system/202192.png",slug:"catrin-rutland",institution:{id:"134",name:"University of Nottingham",country:{id:null,name:"United Kingdom"}}}}]},submityourwork:{pteSeriesList:[{id:"14",title:"Artificial Intelligence",numberOfPublishedBooks:9,numberOfPublishedChapters:89,numberOfOpenTopics:6,numberOfUpcomingTopics:0,issn:"2633-1403",doi:"10.5772/intechopen.79920",isOpenForSubmission:!0},{id:"7",title:"Biomedical Engineering",numberOfPublishedBooks:12,numberOfPublishedChapters:104,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2631-5343",doi:"10.5772/intechopen.71985",isOpenForSubmission:!0}],lsSeriesList:[{id:"11",title:"Biochemistry",numberOfPublishedBooks:32,numberOfPublishedChapters:318,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2632-0983",doi:"10.5772/intechopen.72877",isOpenForSubmission:!0},{id:"25",title:"Environmental Sciences",numberOfPublishedBooks:1,numberOfPublishedChapters:12,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2754-6713",doi:"10.5772/intechopen.100362",isOpenForSubmission:!0},{id:"10",title:"Physiology",numberOfPublishedBooks:11,numberOfPublishedChapters:141,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2631-8261",doi:"10.5772/intechopen.72796",isOpenForSubmission:!0}],hsSeriesList:[{id:"3",title:"Dentistry",numberOfPublishedBooks:8,numberOfPublishedChapters:129,numberOfOpenTopics:2,numberOfUpcomingTopics:0,issn:"2631-6218",doi:"10.5772/intechopen.71199",isOpenForSubmission:!0},{id:"6",title:"Infectious Diseases",numberOfPublishedBooks:13,numberOfPublishedChapters:113,numberOfOpenTopics:3,numberOfUpcomingTopics:1,issn:"2631-6188",doi:"10.5772/intechopen.71852",isOpenForSubmission:!0},{id:"13",title:"Veterinary Medicine and Science",numberOfPublishedBooks:11,numberOfPublishedChapters:106,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2632-0517",doi:"10.5772/intechopen.73681",isOpenForSubmission:!0}],sshSeriesList:[{id:"22",title:"Business, Management and Economics",numberOfPublishedBooks:1,numberOfPublishedChapters:19,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2753-894X",doi:"10.5772/intechopen.100359",isOpenForSubmission:!0},{id:"23",title:"Education and Human Development",numberOfPublishedBooks:0,numberOfPublishedChapters:5,numberOfOpenTopics:1,numberOfUpcomingTopics:1,issn:null,doi:"10.5772/intechopen.100360",isOpenForSubmission:!0},{id:"24",title:"Sustainable Development",numberOfPublishedBooks:0,numberOfPublishedChapters:15,numberOfOpenTopics:5,numberOfUpcomingTopics:0,issn:null,doi:"10.5772/intechopen.100361",isOpenForSubmission:!0}],subseriesList:[],annualVolumeBook:{},thematicCollection:[],selectedSeries:null,selectedSubseries:null},seriesLanding:{item:{id:"11",title:"Biochemistry",doi:"10.5772/intechopen.72877",issn:"2632-0983",scope:"Biochemistry, the study of chemical transformations occurring within living organisms, impacts all areas of life sciences, from molecular crystallography and genetics to ecology, medicine, and population biology. Biochemistry examines macromolecules - proteins, nucleic acids, carbohydrates, and lipids – and their building blocks, structures, functions, and interactions. Much of biochemistry is devoted to enzymes, proteins that catalyze chemical reactions, enzyme structures, mechanisms of action and their roles within cells. Biochemistry also studies small signaling molecules, coenzymes, inhibitors, vitamins, and hormones, which play roles in life processes. Biochemical experimentation, besides coopting classical chemistry methods, e.g., chromatography, adopted new techniques, e.g., X-ray diffraction, electron microscopy, NMR, radioisotopes, and developed sophisticated microbial genetic tools, e.g., auxotroph mutants and their revertants, fermentation, etc. More recently, biochemistry embraced the ‘big data’ omics systems. Initial biochemical studies have been exclusively analytic: dissecting, purifying, and examining individual components of a biological system; in the apt words of Efraim Racker (1913 –1991), “Don’t waste clean thinking on dirty enzymes.” Today, however, biochemistry is becoming more agglomerative and comprehensive, setting out to integrate and describe entirely particular biological systems. The ‘big data’ metabolomics can define the complement of small molecules, e.g., in a soil or biofilm sample; proteomics can distinguish all the comprising proteins, e.g., serum; metagenomics can identify all the genes in a complex environment, e.g., the bovine rumen. This Biochemistry Series will address the current research on biomolecules and the emerging trends with great promise.",coverUrl:"https://cdn.intechopen.com/series/covers/11.jpg",latestPublicationDate:"June 29th, 2022",hasOnlineFirst:!0,numberOfOpenTopics:4,numberOfPublishedChapters:318,numberOfPublishedBooks:32,editor:{id:"31610",title:"Dr.",name:"Miroslav",middleName:null,surname:"Blumenberg",fullName:"Miroslav Blumenberg",profilePictureURL:"https://mts.intechopen.com/storage/users/31610/images/system/31610.jpg",biography:"Miroslav Blumenberg, Ph.D., was born in Subotica and received his BSc in Belgrade, Yugoslavia. He completed his Ph.D. at MIT in Organic Chemistry; he followed up his Ph.D. with two postdoctoral study periods at Stanford University. Since 1983, he has been a faculty member of the RO Perelman Department of Dermatology, NYU School of Medicine, where he is codirector of a training grant in cutaneous biology. Dr. Blumenberg’s research is focused on the epidermis, expression of keratin genes, transcription profiling, keratinocyte differentiation, inflammatory diseases and cancers, and most recently the effects of the microbiome on the skin. He has published more than 100 peer-reviewed research articles and graduated numerous Ph.D. and postdoctoral students.",institutionString:null,institution:{name:"New York University Langone Medical Center",institutionURL:null,country:{name:"United States of America"}}},subseries:[{id:"14",title:"Cell and Molecular Biology",keywords:"Omics (Transcriptomics; Proteomics; Metabolomics), Molecular Biology, Cell Biology, Signal Transduction and Regulation, Cell Growth and Differentiation, Apoptosis, Necroptosis, Ferroptosis, Autophagy, Cell Cycle, Macromolecules and Complexes, Gene Expression",scope:"The Cell and Molecular Biology topic within the IntechOpen Biochemistry Series aims to rapidly publish contributions on all aspects of cell and molecular biology, including aspects related to biochemical and genetic research (not only in humans but all living beings). We encourage the submission of manuscripts that provide novel and mechanistic insights that report significant advances in the fields. Topics include, but are not limited to: Advanced techniques of cellular and molecular biology (Molecular methodologies, imaging techniques, and bioinformatics); Biological activities at the molecular level; Biological processes of cell functions, cell division, senescence, maintenance, and cell death; Biomolecules interactions; Cancer; Cell biology; Chemical biology; Computational biology; Cytochemistry; Developmental biology; Disease mechanisms and therapeutics; DNA, and RNA metabolism; Gene functions, genetics, and genomics; Genetics; Immunology; Medical microbiology; Molecular biology; Molecular genetics; Molecular processes of cell and organelle dynamics; Neuroscience; Protein biosynthesis, degradation, and functions; Regulation of molecular interactions in a cell; Signalling networks and system biology; Structural biology; Virology and microbiology.",annualVolume:11410,isOpenForSubmission:!0,coverUrl:"https://cdn.intechopen.com/series_topics/covers/14.jpg",editor:{id:"165627",title:"Dr.",name:"Rosa María",middleName:null,surname:"Martínez-Espinosa",fullName:"Rosa María Martínez-Espinosa",profilePictureURL:"https://mts.intechopen.com/storage/users/165627/images/system/165627.jpeg",institutionString:null,institution:{name:"University of Alicante",institutionURL:null,country:{name:"Spain"}}},editorTwo:null,editorThree:null,editorialBoard:[{id:"79367",title:"Dr.",name:"Ana Isabel",middleName:null,surname:"Flores",fullName:"Ana Isabel Flores",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRpIOQA0/Profile_Picture_1632418099564",institutionString:null,institution:{name:"Hospital Universitario 12 De Octubre",institutionURL:null,country:{name:"Spain"}}},{id:"328234",title:"Ph.D.",name:"Christian",middleName:null,surname:"Palavecino",fullName:"Christian Palavecino",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y000030DhEhQAK/Profile_Picture_1628835318625",institutionString:null,institution:{name:"Central University of Chile",institutionURL:null,country:{name:"Chile"}}},{id:"186585",title:"Dr.",name:"Francisco Javier",middleName:null,surname:"Martin-Romero",fullName:"Francisco Javier Martin-Romero",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bSB3HQAW/Profile_Picture_1631258137641",institutionString:null,institution:{name:"University of Extremadura",institutionURL:null,country:{name:"Spain"}}}]},{id:"15",title:"Chemical Biology",keywords:"Phenolic Compounds, Essential Oils, Modification of Biomolecules, Glycobiology, Combinatorial Chemistry, Therapeutic peptides, Enzyme Inhibitors",scope:"Chemical biology spans the fields of chemistry and biology involving the application of biological and chemical molecules and techniques. In recent years, the application of chemistry to biological molecules has gained significant interest in medicinal and pharmacological studies. This topic will be devoted to understanding the interplay between biomolecules and chemical compounds, their structure and function, and their potential applications in related fields. Being a part of the biochemistry discipline, the ideas and concepts that have emerged from Chemical Biology have affected other related areas. This topic will closely deal with all emerging trends in this discipline.",annualVolume:11411,isOpenForSubmission:!0,coverUrl:"https://cdn.intechopen.com/series_topics/covers/15.jpg",editor:{id:"441442",title:"Dr.",name:"Şükrü",middleName:null,surname:"Beydemir",fullName:"Şükrü Beydemir",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y00003GsUoIQAV/Profile_Picture_1634557147521",institutionString:null,institution:{name:"Anadolu University",institutionURL:null,country:{name:"Turkey"}}},editorTwo:{id:"13652",title:"Prof.",name:"Deniz",middleName:null,surname:"Ekinci",fullName:"Deniz Ekinci",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002aYLT1QAO/Profile_Picture_1634557223079",institutionString:null,institution:{name:"Ondokuz Mayıs University",institutionURL:null,country:{name:"Turkey"}}},editorThree:null,editorialBoard:[{id:"219081",title:"Dr.",name:"Abdulsamed",middleName:null,surname:"Kükürt",fullName:"Abdulsamed Kükürt",profilePictureURL:"https://mts.intechopen.com/storage/users/219081/images/system/219081.png",institutionString:null,institution:{name:"Kafkas University",institutionURL:null,country:{name:"Turkey"}}},{id:"241413",title:"Dr.",name:"Azhar",middleName:null,surname:"Rasul",fullName:"Azhar Rasul",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRT1oQAG/Profile_Picture_1635251978933",institutionString:null,institution:{name:"Government College University, Faisalabad",institutionURL:null,country:{name:"Pakistan"}}},{id:"178316",title:"Ph.D.",name:"Sergey",middleName:null,surname:"Sedykh",fullName:"Sergey Sedykh",profilePictureURL:"https://mts.intechopen.com/storage/users/178316/images/system/178316.jfif",institutionString:null,institution:{name:"Novosibirsk State University",institutionURL:null,country:{name:"Russia"}}}]},{id:"17",title:"Metabolism",keywords:"Biomolecules Metabolism, Energy Metabolism, Metabolic Pathways, Key Metabolic Enzymes, Metabolic Adaptation",scope:"Metabolism is frequently defined in biochemistry textbooks as the overall process that allows living systems to acquire and use the free energy they need for their vital functions or the chemical processes that occur within a living organism to maintain life. Behind these definitions are hidden all the aspects of normal and pathological functioning of all processes that the topic ‘Metabolism’ will cover within the Biochemistry Series. Thus all studies on metabolism will be considered for publication.",annualVolume:11413,isOpenForSubmission:!0,coverUrl:"https://cdn.intechopen.com/series_topics/covers/17.jpg",editor:{id:"138626",title:"Dr.",name:"Yannis",middleName:null,surname:"Karamanos",fullName:"Yannis Karamanos",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002g6Jv2QAE/Profile_Picture_1629356660984",institutionString:null,institution:{name:"Artois University",institutionURL:null,country:{name:"France"}}},editorTwo:null,editorThree:null,editorialBoard:[{id:"243049",title:"Dr.",name:"Anca",middleName:null,surname:"Pantea Stoian",fullName:"Anca Pantea Stoian",profilePictureURL:"https://mts.intechopen.com/storage/users/243049/images/system/243049.jpg",institutionString:null,institution:{name:"Carol Davila University of Medicine and Pharmacy",institutionURL:null,country:{name:"Romania"}}},{id:"203824",title:"Dr.",name:"Attilio",middleName:null,surname:"Rigotti",fullName:"Attilio Rigotti",profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",institutionString:null,institution:{name:"Pontifical Catholic University of Chile",institutionURL:null,country:{name:"Chile"}}},{id:"300470",title:"Dr.",name:"Yanfei (Jacob)",middleName:null,surname:"Qi",fullName:"Yanfei (Jacob) Qi",profilePictureURL:"https://mts.intechopen.com/storage/users/300470/images/system/300470.jpg",institutionString:null,institution:{name:"Centenary Institute of Cancer Medicine and Cell Biology",institutionURL:null,country:{name:"Australia"}}}]},{id:"18",title:"Proteomics",keywords:"Mono- and Two-Dimensional Gel Electrophoresis (1-and 2-DE), Liquid Chromatography (LC), Mass Spectrometry/Tandem Mass Spectrometry (MS; MS/MS), Proteins",scope:"With the recognition that the human genome cannot provide answers to the etiology of a disorder, changes in the proteins expressed by a genome became a focus in research. Thus proteomics, an area of research that detects all protein forms expressed in an organism, including splice isoforms and post-translational modifications, is more suitable than genomics for a comprehensive understanding of the biochemical processes that govern life. The most common proteomics applications are currently in the clinical field for the identification, in a variety of biological matrices, of biomarkers for diagnosis and therapeutic intervention of disorders. From the comparison of proteomic profiles of control and disease or different physiological states, which may emerge, changes in protein expression can provide new insights into the roles played by some proteins in human pathologies. Understanding how proteins function and interact with each other is another goal of proteomics that makes this approach even more intriguing. Specialized technology and expertise are required to assess the proteome of any biological sample. Currently, proteomics relies mainly on mass spectrometry (MS) combined with electrophoretic (1 or 2-DE-MS) and/or chromatographic techniques (LC-MS/MS). MS is an excellent tool that has gained popularity in proteomics because of its ability to gather a complex body of information such as cataloging protein expression, identifying protein modification sites, and defining protein interactions. The Proteomics topic aims to attract contributions on all aspects of MS-based proteomics that, by pushing the boundaries of MS capabilities, may address biological problems that have not been resolved yet.",annualVolume:11414,isOpenForSubmission:!0,coverUrl:"https://cdn.intechopen.com/series_topics/covers/18.jpg",editor:{id:"200689",title:"Prof.",name:"Paolo",middleName:null,surname:"Iadarola",fullName:"Paolo Iadarola",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bSCl8QAG/Profile_Picture_1623568118342",institutionString:null,institution:{name:"University of Pavia",institutionURL:null,country:{name:"Italy"}}},editorTwo:{id:"201414",title:"Dr.",name:"Simona",middleName:null,surname:"Viglio",fullName:"Simona Viglio",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRKDHQA4/Profile_Picture_1630402531487",institutionString:null,institution:{name:"University of Pavia",institutionURL:null,country:{name:"Italy"}}},editorThree:null,editorialBoard:[{id:"72288",title:"Dr.",name:"Arli Aditya",middleName:null,surname:"Parikesit",fullName:"Arli Aditya Parikesit",profilePictureURL:"https://mts.intechopen.com/storage/users/72288/images/system/72288.jpg",institutionString:null,institution:{name:"Indonesia International Institute for Life Sciences",institutionURL:null,country:{name:"Indonesia"}}},{id:"40928",title:"Dr.",name:"Cesar",middleName:null,surname:"Lopez-Camarillo",fullName:"Cesar Lopez-Camarillo",profilePictureURL:"https://mts.intechopen.com/storage/users/40928/images/3884_n.png",institutionString:null,institution:{name:"Universidad Autónoma de la Ciudad de México",institutionURL:null,country:{name:"Mexico"}}},{id:"81926",title:"Dr.",name:"Shymaa",middleName:null,surname:"Enany",fullName:"Shymaa Enany",profilePictureURL:"https://mts.intechopen.com/storage/users/81926/images/system/81926.png",institutionString:"Suez Canal University",institution:{name:"Suez Canal University",institutionURL:null,country:{name:"Egypt"}}}]}]}},libraryRecommendation:{success:null,errors:{},institutions:[]},route:{name:"profile.detail",path:"/profiles/158043",hash:"",query:{},params:{id:"158043"},fullPath:"/profiles/158043",meta:{},from:{name:null,path:"/",hash:"",query:{},params:{},fullPath:"/",meta:{}}}},function(){var e;(e=document.currentScript||document.scripts[document.scripts.length-1]).parentNode.removeChild(e)}()